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ABSTRACT 
 
Ahmed-Rufai Ibrahim: Synthesis & Characterization of Film Defects in Coatings and 
Degradation of Polymeric Materials  
(Under the direction of Valerie Sheares Ashby and Frank A. Leibfarth) 
 
 The field of macromolecular science has explored the ability of invoking high degrees of 
functionality to increase the applications in which materials may be utilized.  In doing so, new 
characterization methodologies are necessary to better qualify and quantify their abilities and 
understand the dynamics behind their novel performance.  This dissertation describes both of 
these areas, including the development of characterization methods for understudied biopolymers 
and emulsion-produced latexes, as well as the synthesis of novel polymers for achieving on-
demand, segmented material depolymerization. 
 In Chapter 2, a method was developed for investigating the role of different constituents 
of an acrylic coating in creating film defects.  The defect of film sag was studied utilizing an 
electron paramagnetic resonance (EPR) spin probe. The probe allowed the curing process of a 
coating to be surveyed and how the binder of the coating responds to coalescence.  By doing this 
for both horizontal and vertical orientations, the sag film defect was observed by a variation in 
polarity of the spin probe.  This polarity was evident in the spectra of the probe and its shift in 
polarity was quantified over time. 
 In Chapter 3, synthesis goals turn to creating copolymers possessing novel functionalities 
for use in self-healing materials and drug delivery methods.  The described system utilizes self-
immolative polymers (SIPs) to enable selective, on-demand depolymerization of materials. The 
	 	
	
	
	 iv 
triggers investigated were pH and heat, due to their relevance and abundance of use in biological 
applications.  The synthesized polymers were able to be depolymerized to their monomeric 
parent molecules discriminately based on the stimulus which the copolymer was exposed to.  
Various characterization methods were utilized to ensure the kinetics of depolymerization, as 
well which material was depolymerized, could be controlled.  To investigate the viability of this 
system in drug delivery, biologically relevant copolymers were synthesized to be incorporated in 
multi-dye possessing polymersomes capable of on-demand release of said dyes in response to 
orthogonal stimuli. 
 Chapter 4 elucidates a method developed for the improvement of mucin characterization.  
Mucins are the macromolecules which make up mucus. The abundance of various mucins 
plagues patients with Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD).  
These patients utilize mucolytic agents, which are reducing agents that break down mucins. 
These agents, however, are largely ineffective and unsuccessful in their attempts to depolymerize 
mucins to-date.  To aid mucolytic drug development and better understand the mechanism of 
mucin reduction, the described method aims to create more accurate molecular weight and size 
determination of mucins using Gel Permeation Chromatography (GPC) and Dynamic Light 
Scattering (DLS). 
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CHAPTER 1: INTRODUCTION TO SYNTHESIS & CHARACTERIZATION OF 
DEFECTS IN COATINGS AND DEPOLYMERIZATION IN POLYMERIC 
MATERIALS 
 
1.1 Overview 
This dissertation describes the synthesis and characterization of film defects within 
acrylic-based coatings for optimizing formulation methods.  It also describes the synthesis, 
characterization, and stimulus-dictated kinetics of selectively depolymerized diblock copolymers 
which respond to orthogonal stimuli on-demand.  Section 1.2 reviews pertinent information 
regarding film defects, how they arise, their importance, the chemistry behind them, and current 
methods to qualify them.  Section 1.3 provides detail on the background of purposely-degradable 
materials, their synthesis, and their applications.  This work also investigates methods for 
characterizing mucins for advancing the scientific understanding of these macromolecules.  
Section 1.4 offers insight on the field of mucins, current characterization techniques and their 
shortcomings, and drug development methodologies of mucolytic agents. 
1.2 Introduction to Defects in Coatings 
1.2.1 Surface Defects in Coatings 
 The post-World War II employment of emulsion polymerizations in the production of 
plastics has allowed for great advancement in latex coatings.1 Films are now capable of 
possessing countless properties, making them useful in every industry.  Though the bulk of the 
film layer may bear functionality vital to its application, of most importance is the surface of the 
cured film.  Gloss/sheen, film washability, chemical resistance, and blocking (ability to act as a 
	 	
	
	
	 2 
barrier) are a few of many properties determined by the cured surface.2 Appearance, however, is 
the primary property which must be perfect to the end-users of most formulated paints.2 It is also 
the most difficult property to reproduce on a batch-to-batch basis.   
 Paints contain dispersions of multiple components, which must be formulated at optimal 
concentrations so that they complement each other’s performance before, during, and after 
application.  In addition, the order in which these components are added during the 
manufacturing process, and the processing conditions, must be ideal.  A small lapse in the 
specificity of these three factors can cause film defects to occur on the surface of the cured 
product.3 Because coatings are initially liquids and become a solid film after being applied on a 
substrate, numerous factors in the application and curing process play a role in altering the 
surface of the coating as well.  The application process can lead to defects based on the method, 
applicator used, and thickness of the applied wet film.  During the curing process, environmental 
conditions and orientation of the substrate create variables that affect the rate of cure and the 
flow of the coating, which can also create defects in the cured film. 
1.2.1.a Craters 
Dimples on the surface of a film, referred to as “craters”, are a common defect as a result 
of contaminants existing on, in, or under the paint, creating non-uniform surface tension.2 Oils, 
fibers, dirt, and poorly dispersed additives are typical contaminants and tend to evaporate during 
the drying process or rest within the cured film.  The surface tension gradient sends flow of the 
paint away from the lower surface tension created by the contaminant, as depicted in Fig. 1.1. If 
the viscosity of the paint is too high to allow flow at that point of the cure, the crater will remain 
in the solid state.3 
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Figure 1.1 Illustration of cratering and the film flow at the defect 
 
1.2.1.b Air Entrapment 
Spraying and stirring paint often leads to another common surface defect by mixing in 
air.  Air entrapment is typically evident upon application as foam formation on the surface.  The 
gas can also derive from the substrate, and can become trapped underneath the film once the 
coating is applied.3   If gas is unable to escape before film formation begins, the gas penetrates 
the film and leaves holes behind.  In the case of air trapped on the paint/substrate interface, the 
lifetime of the coating can be drastically affected by the created vulnerability of contaminants 
and solvents having a path to reach the substrate.3 
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1.2.1.c Sag 
As coating technologies move toward environmentally friendly formulations and reduce 
the amount of volatile organic compounds (VOCs) they contain, the typical concentration of 
solids in coatings has increased significantly.  As a result, the most frequent film defect is the 
occurrence of sag.  On an inclined substrate, an applied coating’s flow is used to create a level 
surface.  The flow and leveling potentials of paints are determined by their rheology properties, 
the density of the coating, and the degree of inclination of the substrate.  A coating which is not 
viscous enough to flow at a rate optimal for its curing kinetics will flow too fast and create a 
gradient in film thickness, growing in size as it travels downward as depicted in Fig. 1.2.  
 
Figure 1.2 Illustration of the uneven film caused by sag 
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 As evident by sag, a formulated paint which satisfies appearance on a horizontal 
substrate may not necessarily produce satisfactory results on a vertical substrate, and vice versa.  
Though rheology modifiers and concentrations of solvents are the primary culprit from a 
formulation standpoint, error during application and the environmental conditions of the cure are 
necessary to consider as well.4   Take for example applying paint using a paintbrush.  By the 
natural motion of a stroke using a brush, maximum shear is applied at the midpoint of the stroke, 
and lessens as the brush reaches the bottom of the stroke until it is removed from the substrate.  
This creates an inherent ascent in film thickness as you move down the substrate.  Formulators 
rely on the flow of the paint to level the coating as described previously, however, if the 
environment is one which promotes a rapid cure, sufficient flow cannot be achieved and sag 
occurs. 
1.2.2 Theory of Sag 
 Because of the vertical orientation of the substrate, an applied coating feels the effects of 
gravity, g, as a function of its density, ρ.  Though this is true for the net stress experienced 
throughout the coating, each layer of the paint experiences an added stress due to the weight of 
the layer on top of it.  This is displayed in the graphic of Fig. 1.3, where the layer closest to the 
substrate, at distance y, is the one which experiences the most stress due to the weight of the 
other layers at a distance (h-y).  The magnitude of this stress can be calculated using equation 
(1).5   The typical stress on the surface of an architectural paint film was determined by Patton6 
to be 0.8 Pa. From this understanding, we can use equations (2)5 and (3)5 to provide quantitative 
information on the velocity of flow witnessed on the surface and the bulk flow of a Newtonian 
coating.3 
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Figure 1.3 Relevant forces for the curing of Newtonian coatings 
 
Newtonian liquids provide a good basis for understanding what factors play a role in the 
curing of coatings on a vertical substrate, but do not tell a complete story in modern coatings.  
Paints are ideally formulated to be shear thinning, that is, they flow better when stress is applied 
and exhibit high viscosity under no stress (Fig. 1.4).  Such a rheology behavior is preferred so 
that sag can be minimized during curing for achieving optimal appearance and coating coverage 
of the substrate without sacrificing ease of application for the end-user.   
 
Figure 1.4 Plot of common fluid property profiles 
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Because the viscosity of the film changes during the curing process, the variation in wet 
film thickness and viscosity as a function of time must be considered.  Orchard et al.7,8 and 
Overdiep9,10 studied this rigorously and determined that the total film flow, ψ∞, can be measured 
by the following equation: 
ò
¥
¥ = 0
3
)(
)( dt
t
th
h
y        (4) 
 Though a change in film thickness during the curing process in liquid paints does occur 
as the solvent leaves the coating, it is marginal, thus h3(t) is relatively constant.   
The inverse of the time-dependent viscosity, [η(t)-1], is regarded as the fluidity of the coating.  
The integration of the fluidity over the time period of the curing process results in the paint flow 
at time t, [PF(t)].  Using Eq. (4) in conjunction with the density of the coating and inherent force 
of gravity, the amount of sagging can be evaluated by; 
   ¥¥ = y
ar
3
singS        (5) 
where α is the angle of inclination of the substrate.  This means that sin (α) =1 for most 
traditional architectural substrates.  The value of S∞ provides information on the amount of a 
coating that passes a fixed position on a sloped substrate.9,10 
1.2.3 Methods of Studying Sag in Coatings 
 Until 30 years ago, qualitative methods have been predominantly used over quantitative 
ones to observe sag in paints.  In the coatings industry, technicians rank a coatings ability to sag 
by visually observing the occurrence after being applied on a vertical panel at different film 
thicknesses (ASTM D 3730, 440).  The tear-dropping of the paint into the next level of thickness 
is used to measure the failure.  From this information, the technician makes reformulation 
	 	
	
	
	 8 
recommendations which typically involve an adjustment in concentrations of the rheology 
modifiers present.  This approach is quick, but gives little information on the role of the many 
components within the coating.  Because of this, only the rheology modifiers are manipulated, 
which can have a drastic effect on the end-use properties of the film as well as the shelf-life of 
the coating.11   Another disadvantage is that this reformulation must use a trial and error 
methodology. 
 The prevalence of rheometers and their use in understanding the curing properties of 
coatings began in the late 1980’s, and their use played an integral role in understanding rheology 
properties in the curing of films.  The response of the coating to gradually increased shear and 
subsequent relaxation has been tied to the flow and leveling properties, as well as the potential 
for sag.  The information generated does allow formulators to understand what film defects may 
occur upon application, but is limited by the model only being relevant for that particular base.  
A coating using a different polymeric binder or different pigment volume concentration will 
need to use a different model for understanding curing dynamics.  In order to aid in this, coatings 
companies set specifications on the viscosity a paint should possess at certain levels of shear to 
create formulation databases. 
 Most recently developed is the use of the Sag and Leveling Surface Analyzer (SALSA) 
method, designed in 2006 by in the Bosma laboratory.12   This technique uses a sinusoidal 
applicator to create a coating on a substrate with a rippled surface.  The wavelength and 
amplitude of this sinusoidal surface are of known value based on the applicator.  The substrate is 
titled to a set angle and the increase in the wavelength due to the flow of the paint is measured.  
A cartoon of this is depicted in Figure 1.5. 
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Figure 1.5 Illustration of the SALSA technique (ridges on the substrate not shown to scale, used 
with permission from author)12 
 
 The apparatus is also equipped with a camera which detects the shift in gloss and records 
images as the coating dries.  The data obtained from the shift in the shape of the surface as well 
as the gloss measurements gives information on the amount of sag which takes place for the 
coating.  Similar to rheometry, this method allows a temperature dependence on flow to be 
realized as well by imposing a ramped heating environment during the curing process.  
 The aforementioned techniques are all engineering mechanisms for witnessing sag and 
projecting its occurrence based on rheology, but do not give information on the nature and 
dynamics of the chemical components at play. 
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1.2.4 Research Objectives  
 Electron Paramagnetic Resonance (EPR) has been used in the past to study coatings by 
understanding spin probe immobilization as aqueous dispersions cure,13 as well as the dynamics 
of surfactants in emulsions by doping a colloidal system.14   Work by Soo Sim, recent graduate 
of the Forbes laboratory showed the ability to observe the solvent-dependent motion of polymer 
chains using a covalently–bonded spin probe to capture electron spin information from other 
parts of the chain.15 This work, in conjunction with the doping studies previously conducted on 
polymeric dispersions, has inspired the goal of using a doped coating to witness sag by way of 
Steady State EPR (SSEPR).  Doping a coating with a stable nitroxide radical can allow the 
motion of the latex to be assessed as a function of the percentage of the film cured over time.  
Because the latex of the paint is most responsible for the flow and leveling properties, it is the 
component which we will focus on for information on sag.  The Forbes laboratory has a specially 
designed wafer cavity, which allows for horizontally oriented samples to be investigated with 
SSEPR. This cavity will allow a comparison of paint samples curing vertically versus those 
curing horizontally and can further confirm the results of sag. 
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Figure 1.6 A coating doped with a nitroxide spin probe as a basis for viewing sag with EPR 
 
 As shown in Fig. 1.6, a concentration gradient of spin probe is hypothesized to form as 
the coating flows and sag occurs.  This can be measured by SSEPR by a change in the intensity 
of the nitroxide spectra.  If said gradient is not evident with the horizontal samples, then it can be 
used as evidence for the existence of sag.   
 In addition, the resulting spectra from the time dependent curing of the coating at ambient 
conditions can be interpreted for evidence of line shape broadening, polarity transitions of the 
nitroxide, and favored nitroxide orientation based on its immobilization.  Gained information 
will allow a detailed understanding of the occurrence of film defects in paints and will be a 
tremendous tool for formulators in designing products which mitigate sag while maintaining 
ideal flow and leveling properties.  In addition, other probes which model components of 
coatings (i.e. surfactant spin probes, polymer backbone or side chain spin probes, thickener-
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based spin probes, etc.) can be utilized in this same fashion to understand their dynamics during 
film coalescence and their stratification in the fully cured film. 
1.3 Degradable Polymers 
1.3.1 Degradation in Materials 
 The purposeful destruction of materials has been used to invoke a multitude of properties 
on everyday polymers, and to create novel functionalities for innovative technologies.  This class 
of materials are referred to as degradable polymers.  They carry a specific set of properties that 
are gradually lost after exposure to a particular stimulus, and can also inherit new properties up 
on degradation.  Based on their inherent chemistry and the degradation method, they provide the 
ability to degrade or depolymerize as a benefit to either the materials physical properties, 
appearance, surface chemistry, or recyclability.16 This vast land of opportunity for the use of 
these materials has led researchers to challenge the status quo of materials and push their 
capabilities using degradation.   
Though there are many opportunities for boosting the scientific knowledge of this field, 
the challenges of these materials cannot be overlooked.  There is an ability to control the 
magnitude of degradation which takes place based on factors such as temperature, pH, polymer 
composition and structure, or percent crystallinity.17 However, increasing or decreasing the rate 
of degradation is not always as simple as modifying the chemistry of the monomer or increasing 
the magnitude of the stimulus.  Another battle scientists face, and maybe the most important, is 
the ability to dictate the degradation products formed through the initial synthesis18.  Full 
degradation is not always achieved, and can cause harmful by-products to aggregate.  In the case 
of biomedical applications, this is extremely important to avoid.  The products of degradation 
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must be able to be metabolized by enzymes or excreted.  If not, their imposed toxicity can be 
life-threatening.19 
1.3.1.a Stimuli-Responsive Polymers  
 Polymers which possess a trigger for stimulus-induced degradation have been created as 
a mechanism to combat random degradation of materials.  In a random degradation event, a 
polymer chain could in theory be cleaved to half of its original size.20 Such an occurrence would 
drastically effect the physical properties of the material if a majority of the chains are degraded 
randomly, thus limiting its use in applications.  Stimuli-responsive polymers can degrade to 
small molecules at controllable rates.  A multitude of stimuli are able to be invoked into 
polymers to aid in recyclability and release of small molecules.21,22  
 Temperature-responsive polymers are of the highest studied. Recent work by Xuan and 
Zhang23 showcases a series of polypeptoids which undergo thermoreversible sol-gel transitions.  
They utilize these transitions to encapsulate enzymes without affecting the enzymes activity or 
structure, giving their material interesting uses in tissue engineering applications.   
 
 
Figure 1.7 Illustration of Polypeptoid-based materials undergoing phase transitions utilizing 
heating and cooling. 
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Another commonly exploited trait of thermoresponsive polymers is a phase transition at a 
lower critical solution temperature (LCST) or upper critical solution temperature (UCST) in 
aqueous solutions.24-34 Researchers utilize the phase transitions of these polymers to affect their 
miscibility, and can release and encapsulate various small molecules due to this.  An example of 
this is in the work of Xu, Meng, and Zhong35, who prepared triblock copolymers consisting of 
poly(ethylene oxide)-b-poly(acrylic acid)-b-poly(N-isopropylacrylamide) to create 
polymerosomes capable of encapsulating and releasing model proteins based on fluctuations of 
the solutions’ temperature.   These polymers are not completely degradable but possess similar 
abilities due to the phase transitions they experience. 
 
 
Figure 1.8 Illustration of phase transition of poly(N-isopropyl acrylamide) (PNIPAM) above its 
LCST 
 
Polymers with disulfide bond linkages between monomers are a useable system for small 
molecule release using reducing agents.  These reduction-responsive polymers possess the ability 
Heat	>	LCST
Poly(acrylic	acid)-block-Poly(N-isopropylacrylamide)
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to degrade through disulfide bond reduction and re-polymerize once oxidized.36 Glutathione and 
N-acetyl cysteine are common agents used to create reducing conditions for these systems, 
however, their efficiency is questionable due to the recombinative nature of free thiols.37-41 This 
is a common degradation method in natural biopolymers due to their many disulfide linkages. 
 
 
Scheme 1.1 Reduction of disulfide bond-containing polymers 
The subset of stimuli-responsive materials which has gained much interest in the last 
decade is field responsive polymers.  This includes photo-42-63, electro-64-91, magnetic-92-97, and 
ultrasound-sensitive98-110 materials. In the case of ultrasound-responsive polymers, ultrasounds 
are used to create gel-to-gel transitions, cleave bonds, and increase solubility.  Zhang et. al.111 
used this ability to release hydrophobic Nile Red dye from the core of poly(ethylene oxide) -
block- poly(lactic acid) (PEO-b-PLA) micelles with a high-intensity focused ultrasound (HIFU) 
created disturbance to the micellar structure. HIFU gained clearance for clinical-use in the 
1990’s and is an ideal method of triggering ultrasound-responsive materials due to its tunability 
and low intensity being tolerable for humans. 
 
Figure 1.9 Illustration of release of a micelle core upon exposure to HIFU 
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1.3.1.b Biodegradable Polymers 
The field of biomaterials has been most active in working to utilize degradable polymers.  
Biological scientists have created numerous combinations of polymers for tissue engineering of 
scaffolds which can assist in tissue repair and degrade away once full healing has occurred, 
vaccines with controlled released to optimize efficacy, hydrogels to assist in superficial healing 
of wounds, and drug delivery vesicles which provide specificity to delivery medications only to 
specific cells or organs.112-116 Table 1.1 displays a list of the common biopolymers which can 
degrade in response to various stimuli. 
 
Table 1.1 Common biopolymers utilized in various biomedical applications 
Name Polymer Structure
Poly(ethylene	glycol)	(PEG)
Poly(lactic acid)	(PLA)
Poly(D-lactic acid)	(PDLA)
Poly(L-lactic	acid)	(PLLA)
Poly(D,L-lactic acid)	(PDLLA) Racemic	mixture of	PDLA	and	PLLA
Poly(caprolactone) (PCL)
Poly(glycolic	acid)	(PGA)
Poly(lactic-co-glycolic acid)	(PLGA)
O
n
O
O
n
O
O
n
O
O
n
O
O
n
O
O n
O
O O
O
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In order to avoid the harmful degradation by-products which can accumulate due to 
partial degradation, researchers have worked to synthesize materials which depolymerize instead 
of degrade.  This involves the polymer degrading to the parent monomer.  To do so, the 
depolymerization reaction must be favored, which involves the entropic contribution to the free 
energy of polymerization outweighing the enthalpic contribution.117 Scientists are creating this 
shift by forcing the polymer to respond to a specific stimulus.  Stimulus-induced 
depolymerization has tremendous implications for a number of fields, including coatings, 
medicine, and waste management.17 
1.3.2 Self-Immolative Polymers 
Towards creating a systematic approach for depolymerizing materials, a class of 
polymers titled self-immolative polymers (SIPs) were developed in 2003.118 These polymers are 
kinetically stable and possess a dormant chain end that responds to a specific stimulus by 
triggering a head-to-tail depolymerization of the polymer (Fig. 1.10).  These polymers have been 
shown to be responsive to a range of stimuli due to the complex triggers they can possess.119   
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Figure 1.10 Illustration of self-immolative polymers and their potential triggers 
 
Though the polymers were only developed less than two decades ago, they are derived 
from the work of Katzenellenbogen, who in 1981 developed a self-immolative phenyl carbamate 
spacer that possessed a trypsin-responsive trigger and a small output molecule (Scheme 1.2).120 It 
was not until 2001 that the Scheeren lab utilized these spacers and turned them into oligomers for 
drug-releasing self-immolative scaffolds, and then self-immolative polymers along with the 
Shabat and McGrath laboratories in 2003.121-123 
 
 
Scheme 1.2 Scheme of the self-immolative spacer developed by Katzenellenbogen in 1981 
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This class of polymers can typically be obtained in a one-pot synthesis which eases their 
manufacturing for mass production.  Small molecules can be bound to functionalities along the 
back bone, which can be released for healing and drug delivery applications. These polymers can 
also be synthesized in a multitude of mechanisms, ranging from step-growth, to emulsion, to 
living polymerizations to control their properties.124-126  
1.3.2.a Enzyme-triggered depolymerization 
 Enzyme-mediated degradation of materials is a highly-sought feature due to its 
implications in biological systems and the abundance of information on enzyme activities and 
kinetics afford tunability for initiating degradation.  Enzymes have successfully triggered 
depolymerization events in SIPs127-134 and were of the first triggers studied in this class of 
polymers.135, 136 Researchers have been able to utilize foreign137,138 and native139 biological 
agents to trigger continuous elimination events in human physiology.  Though optimization is 
still necessary for the full potential of enzyme-triggered depolymerization to be realized in SIPs, 
the goal is for such materials to be used in very complex biological systems where specificity is 
key for success.  
 
 
Scheme 1.3 Common trigger for depolymerization upon exposure to a Penicillin G Amidase 
stimulus 
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1.3.2.b Acid/Base-triggered depolymerization 
 A material’s ability to respond to the pH of its environment is another important feature 
in biological applications which scientists aim to manipulate for optimal degradation kinetics and 
small molecule delivery.128,132,134,140 Most reviewed for their abilities to respond to acidic and 
basic conditions are tert-butoxycarbonyl (Boc) and fluorenylmethyloxycarbonyl (Fmoc) 
protecting groups respectively.  They allow facile depolymerization in SIP systems and the 
kinetics are typically controlled by the concentration and strength of the acid or base used.141,142 
Acid/base triggers are readily available and are easily attached to polymers of various 
functionalities.     
 
 
Scheme 1.4 Boc and Fmoc chemical structures and common triggers (Excess of acid and 
piperidine for Boc and Fmoc respectively) for their cleavage 
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1.3.2.c Photo-triggered depolymerization 
 Photomedicine has been a field of interest to researchers due to its potential for non-
invasive methods and expedited results.  It is the study of how light can be used to advance 
medical treatments and procedures.143 Recent advancements in current photomedicine treatments 
such as photodynamic therapy (PDT) and laser-assisted in situ keratomileusis (LASIK) have 
caused scientists to further explore how current knowledge in photochemistry can be employed 
for creating novel medical as well as industrial products.  In the realm of SIPs, the ultraviolet 
(UV) and near-infrared (NIR) triggers of nitrobenzyl carbamates144 and bromocoumarins145 
respectively, have shown the ability to cleave in response to the appropriate wavelength of light. 
NIR triggers are of special interest due to NIR light’s capacity to penetrate the stratum corneum 
at low intensities145. Such findings of remote activation of depolymerization show promise for in 
vivo applications of SIPs and may lead to the ability for the spatiotemporal control of drug 
release. 
 
Scheme 1.5 UV and NIR-responsive triggers for depolymerization in SIPs 
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Interesting results in the space have lead researchers to push further in attempts to reduce 
the environmental impact of materials.  Enhancing recyclability is one of the major goals of 
global manufacturing sites to align with today’s ideals of creating a sustainable future.  Efforts in 
the synthesis of stimuli-responsive cross-linked and thermoset materials have gained momentum 
in the last five years.  The Long laboratory at Virginia Tech reported in 2014 a recyclable low-
temperature thermoset that is able to reverse cross-links and revert back to its monomers upon 
the addition of a pH=2 aqueous solution.146   The polymer contains a triazine heterocycle, which 
provides thermal stability and increases the thermal glass transition temperature (Tg).  This work 
is promising for the future of enabling an on-demand destruction of high performance polymers. 
1.3.3 Research Objectives 
 Recent discoveries utilizing SIPs have allowed for polymers to be utilized in applications 
which many would think inconceivable decades ago.  However, the work completed thus far is 
common in the sense that the entire material is affected by the exposure of its triggering 
stimulus, whether it be responsive to one or multiple. In this report, we propose the synthesis of 
materials capable of an on-demand, selective depolymerization (Fig. 1.11).  These novel 
materials will possess the ability to undergo depolymerization events only at the portion of the 
material which is triggered based on the stimulus to which it is exposed.  This provides the 
potential to change the appearance, performance, surface, and reactivity of a material 
discriminately.   
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Figure 1.11 Depiction of current approaches in stimuli-responsive depolymerization in contrast to 
the proposed method 
 
Colloidal dispersions provide the ability to deliver a drug or healing agent in a multitude 
of applications.  By incorporating a copolymer in the design of these particles capable of 
depolymerizing in a controlled manner in response to two orthogonal stimuli, efficiency of 
delivery of the micelle core can be increased while solving natural issues.  For example, adverse 
weather has had harsh effects on the agricultural industry. Crops can be treated using 
nanoparticles which systematically depolymerize by heat and light, relying on the prevalence of 
sunlight to deliver a growth aid or pesticide during cold weather.147   Also, as previously 
discussed for biomedical applications, biocompatible vesicles must be able to exit the body or be 
metabolized when delivering drugs or healing bodily tissues without toxic effects. There are 
currently very few FDA-approved depolymerizable biomaterials used for such medical 
applications. Topical analgesics are an example of how drug delivery could benefit from the 
aforementioned particles.  They have limited efficacy and very short durations of action.  Being a 
superficial treatment, the abundance of light can be used to initiate a controlled, extended release 
of medication and ease the troubles of topical analgesic formulation with the permeability of the 
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stratum corneum. Such a method of delivery would increase the efficacy of these topical 
treatments while reducing the need for oral medications, which have toxic side effects.105,107,148   
Bearing the most environmental relevance is the implication this study has for recyclable 
materials.  The ability for a material to depolymerize completely to its parent monomer in a 
facile manner simplifies the recycling process and aids greatly in material renewability.   
 To obtain a selective depolymerization, proposed is the synthesis of a copolymer of SIPs.  
Because of the facile and rapid depolymerization of this class of materials with high selectivity 
for certain stimuli based on the chemistry of the end cap, these polymers are ideal for these 
studies in creating a controlled, yet selective, on-demand depolymerization.  This is further 
illustrated in Figure 1.12. 
 
 
Figure 1.12 Controlled polymer depolymerization for the complete metabolism of copolymer 
systems in the on-demand response to orthogonal stimuli 
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1.4 Mucin Characterization 
1.4.1 Overview of Mucins 
 Naturally produced defense mechanisms are common in biology, allowing living 
organisms to battle foreign, harmful objects to reduce the magnitude of detriment they may 
impose.  In the lungs, the most important of such natural defenses is mucus clearance. 
1.4.1.a Mechanisms of Mucociliary Clearance 
 Mucus lines the epithelial surface of the nasal cavity, mouth, esophagus, trachea, and 
lungs to act as the first line of defense in stopping harmful particulates and pathogens from 
adsorption through the epithelial membrane.149-151 Mucus also possesses enzymes which are 
capable of breaking down and detoxifying molecules so that they may be easily discarded.  The 
human body continuously removes mucus via mucociliary clearance (MCC).152 This involves the 
cilia along epithelial cells “beating” at a frequency which enables removal of mucus with 
pathogens trapped in its gel matrix. As mucus is cleared, mucus is continuously secreted as well 
to ensure constant protection.  Mucus is a viscoelastic layer, and the ability for cilia to clear 
mucus through MCC is dependent on a few factors, including the level of hydration of the mucus 
gel and the mucus type.153 
1.4.1.b Chemical Structure of Mucus 
 Mucus is made up of mucin glycoproteins and can be from 2-45 MDa in relative mass.154 
They are very long macromolecules as well, ranging from a 300 nm to 10 microns.155,156  Mucins 
are built with repeating amino acids and contain a high concentration of serine and threonine.157 
These two amino acids are the sites for O-linked glycosylation, allowing the formation of large 
oligomers.  N-linked glycans, though rare, also exist.  Along the backbone of the biopolymer are 
cysteine-rich domains and globular knots such as von Willebrand Factor D-domains (vWF).158  
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 In humans, mucin genes are termed “MUC#”, the number being related to the order in 
which they were discovered.  There are three major families which these genes are classified 
into.  These are displayed in Table 1.2. 
 
Mucin Gene 
Family 
Secreted, Gel-
Forming 
Secreted, Non-gel 
Forming 
Membrane-associated  
(Cellular receptors) 
MUC gene 
Associated 
MUC5AC 
MUC5B 
MUC2 
MUC3 
MUC19 
MUC7 
MUC1 
MUC4 
MUC11 
MUC13 
MUC15 
MUC20 
Table 1.2 Mucin gene classifications and the associated MUC genes 
 
 In the airways, MUC5AC and MUC5B are the dominant mucins.  While both exist, a 
transgression is observed in the magnitude of each.  As you travel from the mouth inward to the 
bronchial tubes of the lungs, MUC5B becomes less prevalent and MUC5AC predominates the 
physical properties of the mucus.  In saliva, MUC7 is the main mucin expressed due to its 
secretion from serous cells of submucosal glands.159   
1.4.2 Mucin Overexpression in Diseases 
 The rate of mucus secretion is dependent heavily on the immune response of the body to 
foreign objects perceived as harmful.  In the case of diseases, the weakened immune system can 
increase this mucus production due to a higher degree of perception of possible harm imposed by 
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these unknown entities.160 Common disease states and pulmonary conditions which cause a 
hypersecretion of mucus are asthma, chronic obstructive pulmonary disease, and cystic fibrosis. 
In addition to the mucins MUC5AC and MUC5B being overexpressed, a mucous 
substance referred to as sputum is also prevalent in diseased patients.  Sputum contains 
MUC5AC and MUC5B of even higher MW (upwards of 40 MDa), in addition to DNA and other 
proteins.161 Its higher viscosity exacerbates the inability for traditional clearance methods (MCC 
and coughing) to remove bacteria-possessing mucus from the airways.162,163 
1.4.2.a Asthma 
 Asthma is caused by a hyper-responsiveness of the respiratory tract to allergens (i.e. dust 
mites, pollen) or foreign entities (i.e. tobacco smoke, exercise).164 This response occurs via 
inflammation of the airways, leading to coughing, wheezing, and dyspnea.   Mucus 
hypersecretion, bronchospasm, and edema are typical symptoms of asthma. Anti-inflammatory 
and corticosteroid inhalants such as SymbicortÒ, AdvairÒ, and ZenhaleÒ are the current most 
prescribed treatments for chronic ashthma.165 In the case of allergens, it is possible to reverse 
asthmatic symptoms with over-the-counter antihistamines. 
 Bronchial biopsy samples were taken of both asthmatic and healthy patients by Ordonez 
et.al. for comparison of MUC gene expression via reverse transcriptase polymerase chain 
reaction (RT-PCR).  As discussed earlier, MUC5AC is found to be the most prevalent MUC 
gene in the lungs, followed by MUC5B.  The expression of MUC5AC in asthmatic patients was 
found to be 60% higher than that of non-asthmatic pateints, largely increasing the viscosity.166 
This is in line with the noted symptoms of excessive coughing and wheezing.  A function of 
mucus is to protect the respiratory tract from irritation, which excessive coughing creates. 
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1.4.2.b Chronic Obstructive Pulmonary Disease (COPD) 
 COPD is one of the top 10 leading causes of mortality in the world.167-169 Pulmonary 
emphysema170,171 and smooth muscle hypertrophy172,173 are typical factors which cause the 
airflow obstruction signature of COPD.  In some cases, improper epithelial repair is observed as 
well.174  Its onset is commonly attributed to tobacco smoking, indoor pollution, and smoke 
inhalation from cooking in poorly ventilated areas.175-177 To determine at what stage the disease 
has progressed to (from 0=at risk to IV=very severe), physicians measure the forced expiratory 
volume (FEV) and forced vital capacity (FVC) of paitents.175 These values allow for an accurate 
depiction of the magnitude of airflow hindrance the affected patient is experiencing. Because of 
the steadily rising sales of tobacco and nicotine-based products and the increase in air pollution, 
the World Health Organization (WHO) predicts that deaths due to COPD will continue to rise, 
becoming the third leading cause of death in the world by 2020.179 
 In 2014, scientists of the Kesimer lab studied the total mucin concentration of patients 
that were healthy, had mild COPD, had moderate COPD, and had severe COPD.180 The sputum 
samples were analyzed using an interference refractometer with a Sepharose CL2B gel filtration 
column.  The results are shown in Figure 1.13, showing the large increase in mucin concentration 
based on the severity of disease. 
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Figure 1.13 Total mucin concentration data of COPD patients at different stages.  Data 
reproduced from numbers reported by the Kesimer group177 
 
1.4.2.c Cystic Fibrosis (CF) 
 CF is a genetic disease caused by a gene mutation that affects the gene responsible for 
encoding cystic fibrosis transmembrane conductance regulator (CFTR) protein.181 Due to the 
caused lack of bicarbonate-chloride exchange, one of the proteins functions, mucin solubility 
lessens and issues of mucin aggregation occurs.182-184 Images of CF sputum compared to the 
mucus of a healthy patient are seen in Figure 1.14.   
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Figure 1.14 Laser scanning confocal micrograph of normal mucus (A) and sputum of a CF 
patient (B). Image from a review in CHEST with permission from the author**1 
 
CF is most prevalent in white populations (1 in 3000 births are born with CF in this 
ethnic group) and is the most lethal genetic disease for this population, with occurrence most 
prominent in North America and northwest Europe.185 Current life expectancy for a child born 
with the disease is 37 years of age.186 Common symptoms of CF are listed in Table 1.3.  
 
																																																						
**1	Voynow, J. A.; Rubin, B. K.; CHEST, 2009, 135, 2, 505-512	
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Table 1.3 Common symptoms of CF at different stages of life 
 
Symptoms of Cystic Fibrosis
General
• Family history of cystic fibrosis
• Salty-tasting skin
• Clubbing of fingers and toes
• Cough with sputum production
• Mucoid Pseudomonas aeruginosa 
isolated from airway secretions
• Hypochloraemic metabolic alkalosis
Neonatal
• Protracted jaundice
• Abdominal or scrotal calcifications
• Intestinal atresia
Infancy
• Persistent infiltrates on chest 
radiographs
• Failure to thrive
• Chronic diarrhoea
• Abdominal distention
• Cholestasis
• Staphylococcus aureus pneumonia
• Idiopathic intracranial hypertension 
(vitamin A deficiency)
• Haemolytic anaemia (vitamin E 
deficiency)
Childhood
• Chronic pansinusitis or nasal polyposis
• Steatorrhoea
• Rectal prolapse
• Idiopathic recurrent or chronic 
pancreatitis
• Liver disease
Adulthood
• Allergic bronchopulmonary 
aspergillosis
• Chronic pansinusitis or nasal polyposis
• Bronchiectasis
• Haemoptysis
• Idiopathic recurrent pancreatitis
• Portal hypertension
• Delayed puberty
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1.4.3 Common Approaches Toward Mucolysis  
Treatments for CF and COPD have largely been symptom focused and no current 
methods have been able to completely overcome the overexpression of mucins in the respiratory 
tract.  However, work has been done towards reducing the size of mucins via mucolysis, thus 
lowering their viscosity and elasticity so that they may be cleared easier.  These methods include 
the use of non-destructive mucolysis and destructive mucolysis. 
1.4.3.a Non-destructive Mucolysis 
 The impedance on hydration caused by the hydrophobic globular knots along the polymer 
backbone of mucins has led scientists to find methods of unraveling these knots.   To do this, the 
hydrogen bonding and ionic interactions throughout the mucus gel must be interrupted.  
Surfactants have been used as a method for this, including sodium dodecylsulfate187, and dodecyl 
betainate188.  They have shown that reducing the inter-mucin interactions reduce the elastic and 
viscous moduli and can reduce the magnitude of adhesion of mucus to solid substrates.187 Other 
ionic and nonionic agents have been tested as well for their ability to aid ciliary clearance.  
Sodium Chloride189,190 and dextran191 were shown to reduce the crosslink density of mucin 
networks, assisting MCC.   
1.4.3.b Destructive Mucolysis 
 Destructive methods of mucolysis degrade the mucin gel networks by reducing the size 
of the mucins.  Doing so aids in reducing the elasticity of the mucin, allowing them to be cleared 
efficiently through airflow clearance (cough)192 but does not typically assist the burden of ciliary 
clearance.  Dornase alfa is a highly-utilized example.  It is the recombinant human enzyme 
DNase I and has demonstrated the ability to reduce sputum viscosity.193 It does so by decreasing 
the size of DNA molecules within sputum, which are the leading cause of the high viscosity of 
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sputum.194 Dornase alfa does not over-reduce these molecules to a point of liquefying the mucus 
gel so that it retains its necessary functionalities, and was the first FDA approved mucolytic 
prescribed in the United States.195,196  
 N-acetylcysteine (NAC) is another common destructive mucolytic agent.  It is a thiol 
reducing agent that reduces the viscosity of sputum via mucin-chain scission, and though not 
used heavily in North America, has shown efficacy in aiding the clearance of sputum in COPD 
and CF patients.197 NAC reduces disulfide bonds within the mucus gel network to free thiols. As 
more novel disulfide reducing agents have been synthesized by today’s drug makers, NAC was 
found not to be a very efficient therapeutic mucolytic though early in vitro data was 
promising.198-200 The reason for this is unknown and currently being studied by researchers 
worldwide. 
1.4.4 Characterization of Mucins 
1.4.4.a RT-PCR 
 RT-PCR is used to detect gene expression qualitatively by utilizing RNA of interest to 
create complementary DNA transcripts.201 These transcripts are then amplified using PCR, and 
can be used to determine the expressed genes within a biological sample.202,203 This has been 
shown to be highly useful in determining MUC genes in samples166 as well as quantifying the 
magnitude of overexpression of MUC genes in diseased sputum samples204,205, and identifying 
viruses in sputum.206,207 
1.4.4.b Rheology 
 To obtain information about the viscous and elastic modulus of mucin gels, researchers 
turned to trying rheology on these systems.  Rheology is the study of flow, and applies a stress to 
samples and measures the deformation strain of the material in response to this force.208 
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Biological scientist can use this methodology to understand the differences between different 
mucins209, the mucin response under different pH conditions210, 211, and changes in the mucin 
network after mucolysis methods have been applied.212 
1.4.4.c Mass Spectrometry 
 Mass spectrometry methods have been a great tool to both quantify mucins213 and 
characterize them down to the peptides which make them up.214 Its use has changed the way 
scientist can analyze these intricate gels.  Utilizing mass spectrometry as a detector after 
chromatography methods has been quite beneficial for size information and understanding the 
major MUC genes at different locations of the respiratory tract.215  
1.4.4.d. Western Blot 
 To grasp understanding of the molecular weight of mucins and how their size is affected 
under various conditions, western blot is performed.  Western blotting is the staple procedure in 
biomedical research for determining the rough molecular weight of a biological molecule.  It 
involves the gel electrophoresis of native proteins which are stained with antibodies, and 
determining their size based on the resolution of the stained band they create in references to a 
marker of known size.216, 217 This method is what has given the molecular weight estimates of the 
identified MUC genes to-date. Western blot testing has shown that MUC5B and MUC5AC are 
of molecular weights larger than 25 MDa, but because of the nature of the test, cannot provide 
accurate quantitative data.218, 219 
1.4.5 Research Objectives 
 To address the inability to obtain accurate data on the molecular weight of mucins, new 
characterization protocols must be installed.  In this report, we propose the use of gel permeation 
chromatography (GPC) to afford useable data with high impact for drug development and to aid 
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the overall scientific understanding of mucin gel networks in the battle of pulmonary diseases.  
This tool will allow researchers to investigate the role of mucus in lowering patient wellbeing 
and fight mucin overexpression. 
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CHAPTER 2: EPR SPIN PROBE INVESTIGATION OF THE SAG SURFACE DEFECT 
IN ACRYLIC COATINGS DURING FILM COALESCENCE 
 
2.1 Introduction 
A long–standing problem in the drying and curing of commercial coatings is the effect of 
gravity on the superficial layer of the material, i.e., there are often pronounced differences in the 
structure and ultimate physical properties of the coatings as they dry on a vertical versus a 
horizontal surface.  This phenomenon is called "sag" in the coatings industry, which to the best 
of our knowledge has not been studied at the molecular level. Sag causes a coated surface held 
vertically to experience some redistribution of material, with more in the liquid state at the 
bottom of the surface and less at the top.  The drying time may therefore be different for the two 
regions, thus affecting the overall performance and durability of the coating.  
In this paper, we apply the nitroxide spin probe method to investigate sag in commercial 
latex paint using electron paramagnetic resonance (EPR) spectroscopy. The EPR spectrum of a 
nitroxide radical is sensitive to both polarity and viscosity, making this technique highly useful 
for such investigations (Figure 2.1). For a nitroxide radical, the high field nitrogen hyperfine 
tensor component, Azz, is the most sensitive to shifts in polarity of the local environment. This 
sensitivity derives from the electric field produced along the N-O bond (x-axis) of the radical by 
surrounding water molecules.14   The Azz tensor component increases with increasing polarity, 
induced by the hydrogen bonding potential due to neighboring water molecules.  This means that 
the line shape (width, amplitude and phase) is sensitive to molecular motion and ordering, while 
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the high field line of the spectrum can shift noticeably as a function of local polarity. EPR 
spectroscopy has been used in the past to study coatings by understanding spin probe 
immobilization as aqueous dispersions cure to determine the change in migration ability 
molecules experience,1 as well as the dynamics of surfactants during the drying of films by 
varying the length of the hydrophobic tail of the spin probe molecule.2   In our own laboratory 
we have investigated solvent-dependent motion of polymer chains using a covalently–bonded 
spin probe.3  
 
Figure 2.1 Computer simulated EPR spectra of a nitroxide spin probe for different polarities (top 
vs. middle).  The bottom spectrum shows the expected slow motion spectrum of a dry coating. 
Simulations were computed using EasySpin 5.0.2 in MatLab (EPR Simulation Parameters: Fast-
motion Polar Nitroxide (gx, gy, gz: 2.007, 2.003, 2.001/ Ax, Ay, Az: 15, 15, 35), Fast-motion Non-
Polar Nitroxide (gx, gy, gz: 2.0097, 2.0066, 2.0066/ Ax, Ay, Az: 12, 12, 35), Slow-motion Non-
Polar Nitroxide (gx, gy, gz: 2.0078, 2.0058, 2.0023/ Ax, Ay, Az: 5.7, 6, 37.5). 
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As demonstrated in Figure 2.1, doping a coating with a stable nitroxide radical allows the 
polarity and the viscosity of the film to be assessed as a function of drying time.4 Because the 
latex of the paint is most responsible for the flow and leveling properties, we focus on this 
component as the major contributor to sag. As shown in Figure 2.2, in a vertical drying geometry 
(normal for EPR samples), the mobility of the spin probe will be different in different regions as 
sag occurs, with a more mobile region in the lower section of the sample (i.e. slower drying for a 
thicker section of the coating).  We have a specially designed EPR resonator that can be used to 
position the sample completely horizontally for comparison. This can be measured by EPR by a 
change in the line shape and line positions in the EPR spectrum.  
 
 
 
Figure 2.2 A coating doped with a nitroxide spin probe as a basis for viewing sag with EPR 
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2.2 Experimental 
2.2.1 Materials  
The spin probe, 2, 2, 6, 6-tetramethylpiperidine-1-oxyl (TEMPO) (≥98%), Zinc Oxide 
(≥98%), Calcium Carbonate (≥98%), and Titanium (IV) oxide (rutile, ≥99%) were used as 
received from Sigma Aldrich.  2-propanol (Certified ACS Reagent Grade Plus, ≥99.5 %) was 
used as received from Fisher Scientific. The 100% acrylic latex interior coating (Olympic Icon) 
was purchased from a local retailer and used without modification apart from addition of the spin 
probe at low concentrations (10-4 M). 
2.2.2 EPR Spectroscopy  
EPR measurements were acquired using a JEOL FA-100 EPR Spectrometer operating at 
X-band (9.5 GHz) with 100 kHz field modulation. For vertical samples a TE011 cylindrical 
resonator used with the sample mounted.  For horizontal samples a specially designed “wafer 
cavity” with a TM110 mode resonator was employed. A CW light source (Cole-Palmer High-
Intensity Lamp) operating with continuous irradiation at 100W was used in conjunction with the 
wafer cavity for UV exposure experiments.  
2.2.3 Sample Preparation 
A solution of TEMPO (6 x 10-4 M) in 2–propanol was combined with a commercial 
interior coating in a 1:5 ratio, creating a paint sample doped with 10-4 M TEMPO.  This sample 
was coated onto the surface of a flat surface cut into the center of a quartz rod for vertical drying 
measurements, and onto a quartz microscope slide for horizontal drying measurements.  Samples 
were applied to quartz substrates using a doctor blade with a gap set to 50 µm film thickness. 
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2.3 Results and Discussion  
2.3.1 Drying on Vertical Substrates.  
Figure 2.3 (left side) shows the X-band steady-state EPR spectra of a TEMPO-doped 
latex film in a vertical drying geometry over a one hour time lapse.  Very little broadening due to 
slower conformational motion or significant ordering due to immobilization of the spin probe is 
observed. This is somewhat surprising, but is most likely a representation of the difference 
between the drying time (short, one to several hours) vs. the curing time (days or weeks). Drying 
can be expected to lead only to a uniform film, but the film may still provide a highly mobile 
matrix for the probe. The most prominent feature in these spectra is the double peaking observed 
in the high field line, which is highly indicative of a probe experiencing two different 
microenvironments. A substantial shift in the high field hyperfine can be seen as the film goes 
from wet to dry over a time period of 60 minutes. This is manifested in the spectra as different 
values for Azz over time. As the surface dries and cures, the polymer droplets of the latex 
coalesce and the polarity of the coating is lowered due to loss of water and other polar solvents 
from the coating.  A plot of the integrated EPR signal over the first 20 minutes of drying (Figure 
2.3,	right side) shows this transition in more detail.  
 
 
 
 
 
 
Figure 2.3 The film curing process in a vertical drying geometry over one hour as observed by spin probe EPR (left) and the 
integration of the high field hyperfine line and its transition over the first 20 minutes of drying (right). The shift in the high field line 
occurs due to changes in polarity as the more polar solvent molecules evaporate, leaving a less polar polymer microenvironment 
behind. 
53 
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2.3.2 Vertical vs. Horizontal Drying 
To address the issue of whether the spin probe method can indicate the presence of the 
sag phenomenon during drying, comparisons were made to the curing process on a vertical 
substrate for two different positions of the film and substrate in the resonator. The results from 
this study are shown in Figure 2.4. These spectra suggest that there exists a gradient for drying 
along the height of the substrate, which indicates gravity–induced sag.  
 
Figure 2.4 EPR spectra showing the variation in drying of a polymer film based on the position 
of the film and substrate inside the EPR resonator. Left: only the bottom portion of the sample is 
inside the resonator.  Right: only the top portion of the sample is inside. 
 
However, the horizontally dried samples showed no substantial loss in water content over 
the first hour of drying at ambient conditions. This means a difference in drying/curing rate is 
definitely observable for vertical vs. horizontal samples, as shown in a direct comparison of the 
two geometries in Figure 2.5. The spectra of the bottom portion of the substrate in Figure 2.4 
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(left side) closely resemble that of the horizontally dried samples in Figure 2.5. A gradual 
increase in viscosity occurs faster at the top portion of vertical substrate because of the thinned 
film thickness as a result of bulk flow (sag) to the lower portion.			
	
	
Figure 2.5 EPR spectra showing an architectural coating drying in horizontal and vertical 
geometries. 
 
It should also be noted that as the film dries, the EPR signals become less intense over time.  In 
fact, the signals disappear completely on a time scale of 24-48 hours.		
2.3.3 Photo-induced Curing	
 In an attempt to accelerate the slow rate of cure detected during the film curing process of 
the horizontal samples, the samples were exposed to a continuous wave light source.  The wafer 
cavity possesses a special tubular connector which houses a reflective lens.  This lens allows the 
sample within the resonator to be exposed to an external light source.  Fig. 2.6 shows the 
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resulting data, which conveyed a surface cure after 60 minutes when exposed to a UV light 
source.   
 Though temperature change was not observed during these experiments, the exposure to 
light likely creates a warmer environment much like a heating lamp.  It accelerates the 
evaporation of water from the coating and the coalescence of the polymer particles, resulting in 
the rapid rate of cure that is observed. 
 
Figure 2.6 EPR spectra showing the effects of UV light exposure on the nitroxide radical 
 
 The intensity decrease in the samples exposed to UV light was investigated as well.  
During the curing studies, an intrinsic degradation of the TEMPO spin probe was noticed.  In wet 
coating samples which had a dwell time of 48 hours, the spin probe was no longer able to be 
detected by EPR.  Exposure to light causes said degradation to occur significantly faster.  It was 
hypothesized that pigments formulated in the coating, particularly TiO2, were the culprit.  
Samples were prepared containing excess of traditional architectural coating pigments to 
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evaluate their role in the loss of TEMPO over time.  The three tested pigments were zinc oxide 
(ZnO), calcium carbonate (CaCO3), and TiO2. 
 When comparing the results of these samples when cured at ambient conditions and with 
UV light exposure, only TiO2 exhibited a substantial loss in intensity for the nitroxide radical.  
After twenty minutes of exposure, the spin probe was no longer detected, while with no 
exposure, no fluctuation was observed in intensity.  The oxidative degradation of TEMPO by 
TiO2 has been well documented16   and because hindered amines are commonly used in paint 
formulations as light stabilizers, the TiO2 used must be weathered (treated with metal oxides) to 
prevent the magnitude of this occurrence and enhance its photocatalytic stability in drying paint 
films. 
2.4 Conclusions 
For the first time, a coating drying process has been observed using EPR spectroscopy for 
a commercial architectural film. Doping a coating with a spin probe allowed it to associate with 
the polymeric matrix, which dominates its flow and rheology properties.  Fluctuations in the 
nitroxide tensor parameter Azz using a TEMPO spin probe in 2–propanol at a concentration of 
10–4 M provided data related to polarity around the N-O bond.  This information allowed us to 
differentiate between the drying processes for a coating on a vertical substrate versus a horizontal 
substrate, as well as between various heights along the vertical substrate.  Our results have 
significant implications for the use of EPR in the study of sag in paints and other coatings.  
Using spin probes and labels also have the potential to show the effects of film defects. 
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CHAPTER 3: TRIGGERED DEPOLYMERIZATION OF POLYURETHANE-BASED 
MATERIALS IN RESPONSE TO ORTHOGONAL STIMULI  
3.1 Introduction 
The design of precisely triggered degradation in materials is an underdeveloped area of 
macromolecular science. Degradable polymers carry a specific set of properties that are 
gradually lost after exposure to a particular stimulus, and can also inherit new properties upon 
degradation. The rate at which the degradation event occurs is dependent on several factors, 
which could include the pH of the solution, copolymer composition and structure, or percent 
crystallinity.1 Current technologies for degradable polymers, however, have major limitations, 
namely the rate at which complete degradation can be achieved and the nature of formed 
byproducts.  This can be detrimental especially in biomedical applications, where excretion of 
the degraded materials and toxicity of the newly-created degradation products are of paramount 
concern.2  
To address these concerns, researchers have sought to create mechanisms for materials to 
depolymerize completely.  Depolymerization involves the reversion of the polymer back to its 
parent small molecules. In traditional systems, the polymers’ ceiling temperature determines its 
ability to depolymerize.  At this temperature, the entropic contribution to the free energy of 
polymerization outweighs the enthalpic contribution and the reaction equilibrium favors 
depolymerization over polymerization.3   Studies in the field look at ways to create this affinity 
by forcing the polymer to respond to a specific stimulus using a responsive moiety to trigger 
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depolymerization.  Stimulus-induced depolymerization has tremendous implications for a 
number of fields, including coatings, medicine, and waste management.1 
The best-known class of materials capable of this controlled deconstruction of intricate 
macromolecules are self-immolative polymers (SIPs), which were developed in 20034.  These 
polymers are kinetically stable and possess a dormant chain end that responds to a specific 
stimulus to trigger a head-to-tail depolymerization of the polymer.5 These polymers have been 
shown to be responsive to a range of stimuli due to the complex triggers they can possess.  SIPs 
are also typically obtained by pot synthesis methodologies and can store small “output” 
molecules along the polymer backbone.  These features afford them viability for many 
applications.   
A commonality in the studies of SIPs and degradable polymers completed to date is that 
the stimulus-responsive nature of the materials affects the entire material equally and is 
indiscriminate of what portions of the polymer are affected6-12.  Doing so does not afford the full 
potential of a heterogeneous material to be utilized.  A triggered depolymerization of 
heteropolymer blocks independent of one another allows the signature properties which each 
block carries to be lost or exposed on-demand. In this report, we propose the synthesis of 
materials capable of multiple, selective depolymerization events.  These novel, multifunctional 
materials will possess two orthogonal components that have the ability to undergo individual 
depolymerization events.  This provides the potential to change the look, performance, shape, 
and reactivity of a material discriminately.   
To realize such multifunctional materials, we report the synthesis of a diblock copolymer 
of SIPs where each block can individually depolymerize in response to orthogonal stimuli 
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(Figure 3.1).  Because of the facile and rapid depolymerization of this class of materials with 
high selectivity for certain stimuli based on the chemistry of the end cap, these polymers are 
ideal for these studies in creating a controlled, yet selective, on-demand depolymerization.  The 
initial studies will be comprised of the polyacetal, poly(phthalaldehyde) (PPA, 3) as the heat-
sensitive SIP, and the polyurethane, poly(benzyl-4-hydroxymethylphenylcarbamate) (PBHMPC, 
4) will be evaluated as the pH-sensitive SIP.   
 
 
 Figure 3.1 Controlled polymer depolymerization for the complete depolymerization of a 
diblock copolymer system (A) and the depolymerization products of the utilized pH-triggered 
and heat-triggered blocks (B).  
 
PPA is a low ceiling temperature polymer (Tc = -40 °C) and has been shown to allow for 
a controlled depolymerization in response to multiple stimuli.10,15,17 Its low Tc makes it an 
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excellent candidate for thermal depolymerization studies.  End capping the polymer allows it to 
be stable under ambient conditions by preventing the initiation of depolymerization.  
Additionally, this polymer is not susceptible to acid-induced degradation.  PPA has shown use in 
lithography18 and transient electronics.19 
PBHMPC is the most commonly studied SIP to date, having been tested in a multitude of 
triggering conditions.5,17, 18 With the use of a tert-butoxycarbonyl protecting group as its end cap, 
a controlled depolymerization of this polymer is observed.  Provided an excess of acid, the 
formed tert-butyl carbamate of the Boc group becomes protonated and a tert-butyl cation is lost, 
which deprotonates to form isobutylene gas.  Carbon dioxide is released and a head-to-tail 
cascade of 1,6-eliminations forms reactive quinone methide, which in the presence of water 
forms the 4-aminobenzyl alcohol parent molecule (Fig. 3.1B).20-27 To ensure that the self-
immolative nature of this polyurethane cannot be mimicked with similar, yet more stable 
chemistries, an alkyl AB-type monomer was produced (Poly(hydroxypentylphenylcarbamate), 
5).  We also utilized traditional diisocyanate/diol monomers to produce poly[4,4’-
methylenebis(phenyl isocyanate)-alt-1,4-butanediol] (PMDIBD) as a control for the inability of 
these systems to undergo similar depolymerization events when bearing a Boc group end cap. 
The polymer of interest is a diblock copolymer possessing a pH-triggered block and a 
heat-triggered block.  The chain-ends are specifically chosen to respond to orthogonal stimuli, 
which enables mutually exclusive depolymerization. These design parameters allow each block 
to depolymerize fully without affecting the other block. This is further illustrated in Fig. 3.1A.  
In the future, we aim to employ this methodology in the synthesis of self-healing coatings, 
materials with on-demand functionality (adhesives), and mutli-step drug delivery. 
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3.2 Experimental 
3.2.1 Materials and methods 
The monomer o-phthalaldehyde (99%) was used as obtained from TCI Chemicals.  
Tetrahydrofuran (THF) (anhydrous, ≥99.9%), tert-butanol (anhydrous, ≥99.5%), Phosphazene 
P2-t-Bu solution (≈2.0 M in THF), Propargyl Alcohol (99%), 1,4-Butanediol (ReagentPlus®, 
99%), 5-Amino-1-pentanol (95%), Dimethyl sulfoxide (anhydrous, ≥99.9%), Phenyl 
chloroformate (99%), 4-aminobenzyl alcohol (98%), 4-aminophenyl propargyl ether (95%), 
Dibutyltin dilaurate (95%), 4,4’-Methylenebis(phenyl isocyanate) (MDI) (98%), tert-
butyldimethylsilyl chloride (TBSCl) (reagent grade, 97%),  N,N-Dimethylformamide 
(anhydrous, 99.8%), Poly(ethylene glycol) methacrylate (average Mn 360), Oxalyl chloride 
(ReagentPlus®, 99%), 2-(Dodecylthiocarbonothioylthio)propionic acid (97%), Sodium azide 
(ReagentPlus®, ≥99.5%),  3-Chloro-1-propanol (98%), Triethylamine (≥99.5%), Trifluoroacetic 
acid (≥99.5%), and Hydrochloric acid (HCL, ACS reagent, 37%) were used as obtained from 
Sigma Aldrich.  Pyridine (Certified ACS, Suitable for Karl Fischer Reagent ≥99%), Sodium 
Bicarbonate (Certified ACS, ≥99%), Ammonium Chloride (Certified ACS, ≥99.5%), THF 
(Optima™, ≥99.9%), Ethyl Acetate (Certified ACS, ≥99.5%), Dichloromethane (Extra dry, 
99.9%), Ethanol (200 proof), and Hexane (Certified ACS, ≥98.5%) was used as obtained from 
Fisher Scientific. 
1H NMR spectra were recorded on a Bruker 400 AVANCE (400 MHz) using dimethyl 
sulfoxide-d6 or methanol-d4. Thermal properties were measured using a TA Instruments Q200 
DSC (heating rate of 7.5 °C min−1) and a TA Instruments Q5000 TGA (25–550 °C). GPC was 
performed using a Waters 2695 separations module using tetrahydrofuran as the mobile phase (1 
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mL min−1, 25 °C) with a Waters 2414 refractive index detector. Average molar mass was derived 
from a calibration curve based on a series of PS standards ranging from 500 to 100,000 g mol−1. 
ATR FT-IR spectra were recorded on a Bruker ALPHA. 
3.2.2 Synthetic procedures 
3.2.2.a Synthesis of (Hydroxypentyl)phenylcarbamate (1) 
 5-amino pentanol (1.0 g, 9.69 mmol) was suspended in a 15 mL mixture of THF: sat. 
NaHCO3: water (ratio 2:2:1) and Phenylchloroformate (1.04 mL, 8.29 mmol) was added 
dropwise over 5 minutes.  The reaction was monitored to completion by TLC (Ethyl Acetate: 
Hexane 1:1). Ethyl acetate was then added and the organic phase washed twice with saturated 
NH4Cl solution.  The solvents were removed by rotary evaporation and the crude product 
purified by column chromatography on silica gel (Ethyl acetate: Hexane 35:65) to provide the 
monomer as a pale-yellow oil. 1H NMR (400 MHz, DMSO-d6) δ(ppm) 10.24 (1H, s), 7.74 (t, J = 
5.7 Hz, 1H), 7.37 (t, J = 7.7 Hz, 2H), 7.33 – 7.13 (m, 2H), 7.10 (d, J = 8.0 Hz, 2H), 6.78 (d, J = 
7.7 Hz, 1H), 4.42 (t, J = 5.1 Hz, 1H), 3.47 – 3.39 (m, 3H), 3.07 (q, J = 6.6 Hz, 2H), 1.47 (dp, J = 
13.2, 6.8 Hz, 4H), 1.34 (tt, J = 9.7, 5.6 Hz, 2H). 
3.2.2.b Synthesis of Benzyl-4-(hydroxymethyl)phenylcarbamate (2) 
4-aminobenzyl alcohol (1.0 g, 8.13 mmol) was suspended in a 15 mL mixture of THF: 
sat. NaHCO3: water (ratio 2:2:1) and Phenylchloroformate (1.04 mL, 8.29 mmol) was added 
dropwise over 5 minutes.  The reaction was monitored to completion by TLC (Ethyl Acetate: 
Hexane 1:1). Ethyl acetate was then added and the organic phase washed twice with saturated 
NH4Cl solution.  The solvents were removed by rotary evaporation and the crude product 
purified by column chromatography on silica gel (Ethyl acetate: Hexane 35:65) to provide the 
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monomer as a pale yellow solid. 1H NMR (400 MHz, DMSO-d6): δ(ppm) 10.20 (1H, s), 7.45 
(4H, m), 7.19 (5H, m), 5.07 (1H, t, J = 5.6 Hz), 4.43 (2H, d, J = 5.6 Hz). 
3.2.2.c Synthesis of Poly(phthalaldehyde) (3) 
 This synthesis followed a procedure from Peterson.5 A 100 mL round-bottom flask was 
charged with a stir bar and o-phthalaldehyde (3.0 g, 22 mmol) and sealed with a rubber septum.  
The flask was filled with Ar and evacuated by vacuum for three cycles.  Dry THF (37 mL) was 
then added to the flask via syringe.  The flask was then put through three cycles of freeze-pump-
thaw to degas the contents, and backfilled with Ar.  Propargyl Alcohol (4.5 µL, 7.8x10-4 mmol) 
was added to the flask via syringe, and the flask was put into an acetone/dry ice bath.  Once 
cooled to -78 °C, the P2-t-Bu phosphazene base (45 µL, 0.09 mmol) was added to the flask via 
syringe to start the polymerization.  The reaction was allowed to stir vigorously at -78 °C for two 
hours.  Once two hours passed, pyridine (0.9 mL, 11 mmol) and t-butyldimethylsilyl chloride 
(1.1 mL, 5.9 mmol) were sequentially added to the flask.  The reaction was allowed to stir for 
another two hours as the acetone/dry ice bath expired and the reaction returned to room 
temperature.  The contents of the flask were precipitated using an excess of cold methanol (200 
mL) and filtered using a Büchner funnel.  The obtained white solid was dried under vacuum at 
room temperature for 2 hours. 1H NMR (600 MHz, Chloroform-d) δ(ppm) 7.49 (s, 5H), 7.42 (s, 
30H), 7.01 (s, 2H), 6.72 (s, 3H), 6.59 (s, 3H), 1.28 (s, 2H), 0.87 (s, 2H). 
3.2.2.d Synthesis of Poly(benzyl-4-hydroxymethylphenyl carbamate) (4) 
 Monomer 2 (600 mg, 2.48 mmol) and Dibutyltin dilaurate (DBTL) (0.18 mmol) was 
dissolved in dry DMF (1.5 mL), heated to 110 °C under Ar atmosphere, and stirred for 30 
minutes.  Tert-butanol (0.9 mL) was dissolved in dry DMF (1 mL), added to the reaction, and 
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left to stir for an additional 60 minutes.  After cooling to room temperature, the polymer was 
precipitated in methanol as a yellow solid, filtered, and dried under vacuum for 12 hours. 1H 
NMR (400 MHz, DMSO-d6) δ(ppm) 10.19 (s, 1H), 9.80 (s, 8H), 7.48 (d, J = 8.3 Hz, 19H), 7.44 
(s, 1H), 7.44 – 7.26 (m, 19H), 7.30 – 7.12 (m, 6H), 6.76 (t, J = 7.9 Hz, 1H), 6.50 (s, 1H), 5.12 (t, 
J = 5.7 Hz, 1H), 5.06 (s, 17H), 4.43 (dd, J = 12.6, 5.7 Hz, 3H), 2.55 (s, 2H), 1.24 (s, 1H). 
3.2.2.e Synthesis of Poly(hydroxypentylphenyl carbamate) (5) 
 Monomer 1 (300 mg) and Dibutyltin dilaurate (DBTL) (0.18 mmol) was dissolved in dry 
DMF (1.5 mL), heated to 110 °C under Ar atmosphere, and stirred for 30 minutes.  Tert-butanol 
(0.9 mL) was dissolved in dry DMF (1 mL), added to the reaction, and left to stir for an 
additional 60 minutes.  After cooling to room temperature, the polymer was precipitated in 
hexane as a yellow solid, filtered, and dried under vacuum for 12 hours. 1H NMR (400 MHz, 
DMSO-d6) δ(ppm) 7.71 (t, J = 5.7 Hz, 1H), 7.38 (t, J = 7.7 Hz, 2H), 7.32 – 7.12 (m, 2H), 7.10 (d, 
J = 8.0 Hz, 2H), 6.75 (d, J = 7.9 Hz, 1H), 4.51 (t, J = 5.2 Hz, 1H), 3.47 – 3.39 (m, 3H), 3.07 (q, J 
= 6.6 Hz, 2H), 1.47 (dp, J = 13.2, 6.8 Hz, 4H), 1.34 (tt, J = 9.7, 5.6 Hz, 2H). 
3.2.2.f Synthesis of Poly[4,4’-methylenebis(phenyl isocyanate)-alt-1,4-butanediol] (PMDIBD) 
A 25 mL round bottom flask was charged with a stir bar and MDI (393 mg, 1.57 mmol).  
The flask was filled with Ar and evacuated by vacuum for three cycles.  Dry THF (1.5mL) and 
DBTL (2 drops, 0.10 mmol) was added via syringe to the flask, heated to 70 °C, and allowed to 
stir for 90 seconds.  In a separate vial, 1,4 butanediol was added to 1.0 mL of dry THF and 
vortexed for 30 seconds. This mixture was then slowly added to the reaction flask dropwise by 
syringe and allowed to stir for 4 hours.  At that time, tert-Butanol (0.75 mL, 7.97 mmol) was 
added to the reaction via syringe, and allowed to stir for 60 minutes.  The flask was then allowed 
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to cool to room temperature, and the produced polymer was precipitated in cold methanol (200 
mL).  The polymer was collected as a white solid and dried overnight in vacuo. 1H NMR (400 
MHz, DMSO-d6) δ(ppm) 9.52 (s, 1H), 7.35 (d, J = 8.1 Hz, 2H), 7.08 (d, J = 8.2 Hz, 2H), 4.09 (d, 
J = 8.5 Hz, 2H), 3.77 (s, 1H), 3.34 (s, 1H), 1.70 (d, J = 5.3 Hz, 2H). 
3.2.2.g Synthesis of Poly(phthalaldehyde)-b-poly(benzyl-4-hydroxymethyl phenylcarbamate) (6) 
 A 100 mL round-bottom flask was charged with a stir bar, 4 (150 mg, 0.62 mmol) and o-
phthalaldehyde (1.0 g, 7.33 mmol) and sealed with a rubber septum.  The flask was filled with 
Ar and evacuated by vacuum for five cycles, stirring vigorously between the last two cycles.  
Dry THF (11 mL) was then added to the flask via syringe.  The flask was then put through three 
cycles of freeze-pump-thaw to degas the contents, and backfilled with Ar. The flask was put into 
an acetone/dry ice bath.  Once cooled to -78 °C, the P2-t-Bu phosphazene base (45 µL, 0.09 
mmol) in 1mL of Dry THF was added to the flask via syringe to start the polymerization.  The 
reaction was allowed to stir vigorously at -78 °C for two hours.  Once two hours passed, pyridine 
(0.9 mL, 11 mmol) and t-butyldimethylsilyl chloride (1.1 mL, 5.9 mmol, dissolved in 1mL of 
Dry THF) were sequentially added to the flask.  The reaction was allowed to stir for another two 
hours as the acetone/dry ice bath expired and the reaction returned to room temperature.  The 
contents of the flask were precipitated using an excess of cold methanol (200 mL) and filtered 
using a Büchner funnel.  The obtained white solid was dried under vacuum at room temperature 
for 2 hours. 1H NMR (400 MHz, DMSO-d6) δ 9.80 (s, 5H), 7.46 (t, J = 9.8 Hz, 19H), 7.34 (d, J = 
8.2 Hz, 11H), 6.91 (s, 1H), 6.65 (s, 2H), 5.06 (s, 10H), 4.13 (q, J = 5.3 Hz, 11H), 3.26 (d, J = 6.7 
Hz, 1H), 3.17 (d, J = 5.1 Hz, 28H), 2.55 (s, 9H). 
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3.2.2.h Synthesis of 3-Azidopropanol (7) 
Sodium Azide (1.72 g, 26.4 mmol) and 3-Chloro-1-propanol (1.0 g, 10.6 mmol) were 
added to a 100 mL round bottom flask with a stir bar.  DMF (52 mL) was added and the flask 
was sealed and heated to 100 °C.  The reaction was allowed to stir for 48 hours.  The mixture 
was then allowed to cool to room temperature.  The mixture was poured into diethyl ether (40 
mL).  Saturated Aqueous NaCl (100 mL) was added and the organic layer was removed, dried 
over MgSO4, and filtered.  The supernatant was concentrated by rotary evaporation to obtain the 
product (yellow liquid, 89% yield). 1H NMR (400 MHz, Chloroform-d) δ 4.73 (d, J = 8.5 Hz, 
1H), 3.67 (t, J = 5.9 Hz, 9H), 3.41 (s, 2H), 3.39 (s, 5H), 3.37 (s, 2H), 3.17 (s, 5H), 2.96 – 2.82 
(m, 2H), 1.79 (d, J = 6.5 Hz, 6H), 1.26 – 1.12 (m, 1H). 
3.2.2.i Synthesis of 2-(Dodecylthiocarbonothioylthio)propionic acid chloride (8) 
2-(Dodecylthiocarbonothioylthio)propionic acid (0.5 g, 1.43 mmol) was added to a 50 
mL round bottom flask with a stir bar and dissolved with dichloromethane (7.5 mL).  The 
contents of the flask were then cooled to 0 °C while stirring.  Oxalyl chloride (0.14 mL, 1.65 
mmol) was added dropwise under an Ar atmosphere.  The mixture was then allowed to reach 
room temperature and stirred for 3 hours under an Ar atmosphere.  The reaction was then 
concentrated under rotary evaporation to yield the product (dark tan solid, 98% yield). 1H NMR 
(400 MHz, Chloroform-d) δ 11.46 (s, 3H), 5.32 (d, J = 2.1 Hz, 7H), 5.10 (d, J = 9.1 Hz, 2H), 
3.44 (s, 2H), 3.39 (s, 6H), 3.36 (d, J = 7.2 Hz, 1H), 3.32 – 3.23 (m, 2H), 3.27 (s, 2H), 2.90 (dq, J 
= 9.0, 5.2, 4.3 Hz, 2H), 2.56 (s, 1H), 2.47 (s, 5H), 2.26 (s, 1H), 1.92 (t, J = 7.3 Hz, 8H), 1.82 – 
1.59 (m, 20H), 1.50 (s, 1H), 1.47 – 1.35 (m, 11H), 0.93 – 0.85 (m, 23H). 
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3.2.2.j Synthesis of 2-(Dodecylthiocarbonothioylthio)propionic acid 3-Azidopropyl ester (9) 
Molecule 7 (0.265 mL, 2.88 mmol) was added to a 50 mL round bottom with a stir bar.  
The chemical was dissolved in dichloromethane (5 mL) and cooled to 0 °C.  Triethylamine (0.73 
mL) was added to dichloromethane (5 mL) and this mixture was added to the round bottom flask 
dropwise over 10 min.  Molecule 8 (1 g, 2.5 mmol) was added to dichloromethane (5 mL) and 
the mixture was added to the round bottom flask dropwise.  The reaction was allowed to stir for 
3 hours while warming to room temperature.  The solution was then concentrated through rotary 
evaporation and diluted with diethyl ether (100 mL).  This solution was then washed sequentially 
with NaHCO3 (50 mL), H2O (50 mL) and a Brine solution (50 mL).  The washed organic layer 
was dried over MgSO4 and filtered.  The remaining solution was then concentrated through 
rotary evaporation to yield the product (dark orange oil, 92% yield). 1H NMR (400 MHz, 
Chloroform-d) δ 7.28 (d, J = 3.0 Hz, 3H), 4.25 (q, J = 6.6 Hz, 1H), 3.79 (t, J = 6.1 Hz, 3H), 3.49 
(s, 2H), 3.53 – 3.37 (m, 3H), 3.37 (d, J = 7.8 Hz, 2H), 3.00 (s, 1H), 2.00 – 1.81 (m, 4H), 1.71 (t, 
J = 7.9 Hz, 2H), 1.63 (s, 1H), 1.42 (s, 3H), 1.28 (s, 28H), 0.90 (t, J = 6.5 Hz, 5H). 
3.2.2.k Synthesis of Azide-bearing Poly[poly(ethylene glycol)methacrylate] (10) 
Poly(ethylene glycol)methacrylate (0.36 mL, 1 mmol), Azide-bearing chain transfer 
agent 9 (0.015 mL, 0.008 mmol), AIBN (0.6 mg, 0.004 mmol), and dry Dimethylformamide (2.0 
mL) were added to a 25 mL round bottom flask with a stir bar.  The flask was sealed and the 
contents underwent three cycles of freeze-pump-thaw.   The flask was then placed under an Ar 
atmosphere, heated to 90 °C, and allowed to stir for 12 hours. The reaction was quenched by 
placing the flask in liquid nitrogen.  Once allowed to warm to room temperature, the solution 
was precipitated in a 50:50 mixture of diethyl ether and petroleum ether and filtered to retrieve 
the product as a white solid (yield 74%). 1H NMR (400 MHz, Chloroform-d) δ 7.31 (d, J = 18.9 
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Hz, 1H), 3.01 (s, 6H), 2.95 (d, J = 2.7 Hz, 2H), 2.77 (s, 1H), 2.67 (s, 15H), 2.48 (q, J = 8.0, 7.3 
Hz, 1H), 2.32 (d, J = 2.5 Hz, 3H), 2.16 (dd, J = 21.3, 2.5 Hz, 9H), 1.79 (d, J = 2.5 Hz, 6H), 0.68 
(dt, J = 9.4, 4.6 Hz, 1H). 
3.2.2.l Synthesis of Benzyl-4-propargylether(phenylcarbamate) (11) 
4-Aminophenyl propargyl ether (0.25 g, 1.7 mmol) was suspended in a 3.75 mixture of 
THF: saturated NaHCO3: H2O (ratio of 2:2:1 respectively) and Phenylchloroformate (0.23 mL, 
1.8 mmol) was added dropwise. The reaction was monitored to completion by TLC (Ethyl 
Acetate: Hexane 1:1). Ethyl acetate was then added and the organic phase washed twice with 
saturated NH4Cl solution.  The solvents were removed by rotary evaporation and the crude 
product purified by column chromatography on silica gel (Ethyl acetate: Hexane 35:65) to 
provide the monomer as a pale yellow solid (93% yield). 1H NMR (400 MHz, DMSO-d6) δ 
10.09 (s, 1H), 7.42 (dt, J = 7.5, 4.2 Hz, 5H), 7.30 – 7.12 (m, 4H), 7.01 – 6.93 (m, 3H), 4.76 (s, 
2H), 4.76 (d, J = 4.9 Hz, 1H), 3.34 (t, J = 1.5 Hz, 1H). 
3.2.2.m Synthesis of Alkyne-bearing Poly[benzyl-4-hydroxymethyl(phenylcarbamate)] (12) 
Molecule 11 (5 mg, 0.019 mmol) and Monomer 2 (800 mg, 3.31 mmol) and Dibutyltin 
dilaurate (DBTL) (0.18 mmol) was dissolved in dry DMF (1.0 mL), heated to 110 °C under Ar 
atmosphere, and stirred for 30 minutes.  Tert-butanol (0.9 mL) was dissolved in dry DMF (1.0 
mL), added to the reaction, and left to stir for an additional 60 minutes.  After cooling to room 
temperature, the polymer was precipitated in methanol as a yellow solid, filtered, and dried under 
vacuum for 12 hours (92% yield). 1H NMR (400 MHz, DMSO-d6) δ 9.80 (s, 1H), 7.48 (d, J = 
7.9 Hz, 2H), 7.34 (d, J = 8.2 Hz, 2H), 7.18 (dd, J = 22.5, 8.1 Hz, 0H), 7.00 (s, 0H), 6.90 (s, 0H), 
6.75 (d, J = 8.9 Hz, 0H), 6.62 (s, 0H), 6.49 (s, 0H), 5.06 (s, 2H), 4.49 (s, 0H), 4.40 (d, J = 5.6 Hz, 
0H), 3.99 (s, 0H), 2.54 (d, J = 2.4 Hz, 1H), 1.24 (s, 0H). 
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3.2.2.h Film preparation of 4 
 A concentrated sample of the polymer 4 (200 mg in 0.2 mL DMSO) was applied to a 
glass substrate using a doctor blade set to 55 microns.  The film was dried in vacuo using a 
temperature gradient (40 °C to 80 °C over 6 hours, and allowed to dry at 80 °C overnight).  The 
cured polymer film was then cut into equal segments weighing approximately 20 mg.  These 
segments were placed into an aqueous solution containing 40% HCl and 20% ethanol. Initial and 
final weights of the film segments were recorded. 
3.3 Results and discussion 
3.3.1 Polyurethane synthesis and characterization 
3.3.1.a Synthesis of 4, 5, and PMDIBD polyurethanes 
Via nucleophilic substitution, the synthesis of phenyl carbamate-containing monomers 
was achieved with an average yield of 64 ± 3% for monomer 1 and 77 ± 2% for monomer 2 
(Scheme 3.1). 1 and 2 were able to be polymerized via a step-growth mechanism utilizing DBTL 
as the catalyst (Scheme 3.2) to produce 5 and 4 respectively. Relatively high yields were 
recorded (avg. 92 ± 2 %).  The AB-type monomer control, polymer 5 did not possess immolative 
properties when exposed to acidic environments as predicted. This is thought to be due to the 
stability of the polymer backbone which the aliphatic portion of the monomer provides.  5 was 
not studied further in a polyacetal-block-polyurethane copolymer.   
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Scheme 3.1 Synthetic procedure for producing phenyl carbamate-containing monomers. 
The polycondensation reaction of MDI and 1,4 butanediol allowed a facile synthesis of 
the polyurethane PMDIBD.  This polymer did show a slight susceptibility to acid-induced 
degradation.  The speed of this degradation event was not adequate enough for consideration in 
our studies (4.3 % weight loss after 30 days in 10% solution of HCl).   
Each polymer was produced at various molecular weights above their critical molecular 
weight (MWc) to observe any variations on depolymerization rates with respect to chain length.  
The variation between molecular weights were found to be negligible.  Property information of 
the three polyurethanes can be found in Table 3.1.  Each polymer was end capped with a Boc 
group as the trigger to invoke the self-immolative behavior in response to an acidic pH 
environment.  
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Table 3.1 Properties of synthesized polyurethanes 
a Measured by GPC in THF from calibration curves using polystyrene standards. b Measured by 
TGA. 
3.3.1.b pH-induced depolymerization of 4 and PMDIBD  
Utilizing solutions of hydrochloric acid and trifluoroacetic acid, the ability for the 
synthesized polyurethanes to depolymerize in response to an acidic environment was tested.  To 
understand the time scale at which the maximum amount of Boc groups were cleaved per dose of 
acid, we completed a time dependent GPC experiment (Table 3.2). 
 
Sample <Mn>
a
(g/mol)
<Mw>a
(g/mol) PDI
a 5%	degradationb
(°C)
47.5k 7500 8700 1.2 158
412k 12000 17000 1.4 161
413k 13000 18000 1.4 161
54k 4300 4800 1.1 168
510k 9700 13000 1.3 172
514k 14000 19000 1.4 173
PMDIBD4k 4300 6400 1.5 262
PMDIBD13k 13000 19000 1.5 265
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Table 3.2 GPC Data of pH-induced Depolymerization 
 
The average time for the completion of depolymerization upon exposure to an acidic 
environment was roughly four hours for 4 and twenty-two hours for PMDIBD. The data in Table 
3.2 is based on samples being placed in a 10% HCl solution. The weight loss for the 47.5k after 
four hours is roughly 3600 g/mol, equating to approximately a 12% weight loss per hour of 
exposure (based on a 10% HCl solution in THF containing a 5 mg/mL concentration of 47.5k).   
Polymer films were prepared of polymer 4 to observe the solid state depolymerization of 
these materials in an acidic solution. The film segments were placed in an aqueous solution (200 
mg film samples in 5 mL 40% HCl/ 20% Ethanol solution) to assure no dissolution of the film 
47.5k 413k
Time of	
Acid	
Exposure
<Mn>
(g/mol)
<Mw>
(g/mol) PDI
<Mn>
(g/mol)
<Mw>
(g/mol) PDI
Initial 7500 15700 2.10 13000 23400 1.80
1hr 6200 10500 1.70 11000 17000 1.50
2hr 5100 7500 1.50 9200 15000 1.60
3hr 3900 5700 1.50 7800 13000 1.60
4hr 3900 5500 1.40 6100 9900 1.60
5hr 3900 5300 1.40 5300 8600 1.60
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and allow the depolymerization event to be visually assessed. The sample containing the Boc end 
group showed an 89% weight loss (Figure 3.2).  The control sample, which had a polymer with 
no triggering end cap was placed in the sample conditions and showed no significant weight loss. 
Research groups have recently found ways to enhance the ability to control the rate of this 
depolymerization for aromatic carbamates.28 This will be considered in future studies for true 
control over depolymerization kinetics. 
 
 
Figure 3.2   Film depolymerization of 47.5k in an acidic solution.  A) Initial 47.5k film segment, B) 
Control 47.5k film segment which does not possess the Boc group end cap after 60 days of 
exposure.  C) 47.5k film segment possessing the Boc group end cap after 60 days of exposure. 
 
 
A B C
Sample Initial	Weight
(mg)
Final	Weight	
(mg)
%	of Film	Lost
47.5k with	Boc 198 22 89%
47.5k	without	Boc 201 195 3%
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3.3.2 Polyacetal synthesis and characterization 
3.3.2.a Synthesis of polyacetal 3  
The synthesis of 3 proceeds via an anionic polymerization utilizing the phosphazene base 
solution P2-t-Bu.  The reaction takes place at -78 °C to allow propagation. Due to its low ceiling 
temperature, 3 must be end capped before the temperature is raised to prohibit depolymerization. 
The average yield of this polymerization was 61 ± 5%.  The incorporation of the propargyl 
alcohol into the polymer allows for the possibility for interesting “click” chemistry modifications 
to the polymer due to the alkyne’s ability as a reactive moiety.  The phosphazene solution is a 
very strong base (pKa 21.45) and uses a hindered neutral nitrogen to activate the alcohol through 
hydrogen bonding.29 This induces a negative charge on the oxygen of the alcohol, and this 
nucleophile attacks the aldehyde carbon of the monomer.  This creates an oxygen anion, which 
then acts as a nucleophile and attacks the neighboring aldehyde carbon. The propagation of the 
polymer proceeds in this manner, with the phosphazene base aiding the stability of the 
nucleophile (Scheme 3.2).  
3.3.2.b Heat-induced depolymerization of 3 
To assess the viability for 3 to be used as a thermal depolymerization block, the rate of 
depolymerization in solution was determined at a temperature above the Tc of the polymer.  
Using a controlled temperature water bath, samples of 3 (0.75mL samples with 5 mg/mL of 3 in 
CDCl3) were placed into the bath for different increments of time.  Every ten minutes, a sample 
was removed from the bath and placed in to the freezer to halt the depolymerization.  The 1H 
NMR of these samples showed the steady increase in the o-phthalaldehyde monomer (Figure 
3.3A). 
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Fig. 3.3 1H-NMR Data of o-phthalaldehyde monomer formation over time (A), plot of 
depolymerization of 3 over time based on 1H NMR data (B) and plot of controlled 
depolymerization of 3 based on 1H NMR data (C) 
 
From the integration of the peak associated with the aldehyde proton at 10.57 ppm, the 
amount of monomer present was used to determine the new average degree of polymerization 
(Xn).  Relating this to the known Xn for the polymer gives a percent of depolymerization for the 
sample.  The plot of this data allows for the extraction of the rate of depolymerization at this 
temperature (Figure 3.3B). The studies of the depolymerization of 3 based on temperature 
confirm its innate ability due to its low ceiling temperature.  It is inferred that increasing and 
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decreasing the temperature can control the rate at which depolymerization occurs in the 
homopolymer based on these results.  
Using a 10 mL sample of 3 (5 mg/mL) in deuterated chloroform, the ability to slow the 
rate of depolymerization based on temperature was assessed.   The sample was placed in a water 
bath at 65 °C for fifteen minutes, after which point an aliquot was taken and stored at -4 °C.  The 
sample was then stored at -4 °C for an hour.  Another aliquot was removed and left in the freezer 
and the sample was replaced back into the water bath for another fifteen minutes.  This 
procedure was repeated for four cycles, and resulted in the data depicted in Fig. 3.3C.  The 
kinetics are shown to slow in Fig. 3.3C without halting because the exposed hemiacetal of the 
chain end will still favor depolymerization by hemiacetal eliminations at temperatures close to 0 
°C.  In order to obtain a temperature dependent quench of the depolymerization at a more 
feasible temperature, a polymer with a slightly higher Tc must be used.  This may be achieved by 
a modification to polymer 3 in order to reduce the frequency of O-C-O bonds along the polymer 
backbone. Groups have also utilized substituted phthalaldehydes to create a more stable PPA.17 
3.3.3 Multi-responsive block copolymer synthesis and characterization 
3.3.3.a Synthesis of 6 
  The ability of P2-t-Bu to activate an alcohol for initiating the polymerization of o-
phthalaldehyde allowed the use of the synthesized polyurethanes as a macroinitiator for the 
formation of the polymer 3 block of the copolymer (Scheme 3.2).  Overnight stirring and 
exhaustive degassing of the macroinitiator and phthalaldehyde monomer were critical in 
obtaining conversion percentages large enough for the properties of the added block to be 
realized.  The average yield of this reaction was slightly better than that of the 3 homopolymer 
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(73 ± 3%).  Data obtained from the GPC of the formed polymers are shown in Table 3.3.  
Polymers 612k and 628k utilized the 47.5k and 413k polymers respectively as the macroinitiator. 
 
 
Table 3.3 GPC data of synthesized polymer 6 
3.3.3.b Depolymerization studies of 6 
To understand the ability to depolymerize the blocks of the copolymer independently 
without affecting the neighboring block utilizing orthogonal stimuli, NMR was used (Fig. 3.4).  
Dissolving samples in DMSO-d6, samples were exposed to the two stimuli in stages and their 
response to the stimuli were investigated via 1H NMR scans.  Because the polyacetal block bears 
key attributes which resolve nicely in NMR, we were able to follow the depolymerization of this 
block and the unaffected nature of the polyurethane block. 
Sample <Mn>(g/mol)
<Mw>
(g/mol) PDI
612k 12000 25000 2.08
628k 28000 39000 1.40
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Figure 3.4 Time-dependent NMR spectra of 612k after being exposed to various temperatures 
showing the growth of the o-phthalaldehyde monomer (A) and the kinetics of monomer 
formation for the different temperatures assessed (B).  
 
In Figure 3.4A, the ability to depolymerize PPA was observed by the emergence of the 
phthalaldehyde monomer.  Three samples of 612k (15 mg in 5mL DMSO-d6) were placed in 
independent heat baths of 55 °C, 80 °C, and 100 °C.  A 0.6 mL aliquot of each sample was taken 
every 60 minutes and analyzed by 1H NMR.   
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As previously noted, the pure monomer’s 1H NMR possesses a doublet of doublets at 
7.85 ppm from the protons along its benzene ring and a singlet at 10.57 ppm due to the two 
formyl groups placed ortho from each other along the benzene. Inside of the boxed region of the 
spectra in Fig. 3.4A, the growth of these two peak groups are readily observed.  Also within this 
region, the doublet of doublets at 7.39 ppm associated with protons of the benzyl backbone of 
polymer 4 and the singlet at 9.74 ppm associated with the proton of the repeat urethane linkages 
on the polyurethane polymer chains are observed to remain constantly unaffected by the added 
heat. By integrating the aldehyde peaks, we were able to deduce the kinetics of depolymerization 
due to heat for polymer 612k at various temperatures.  These results for the PPA block are 
displayed in Fig. 3.4B.  From the values, we found that the rates of depolymerization are 0.83 
monomeric units/min, 0.33 monomeric units/min, and 0.11 monomeric units/min for 100 °C, 80 
°C, and 55 °C respectively. These rates are slightly slower than those found for the homopolymer 
PPA, which is expected due to the presence of the more heat-stable PBHMPC block.  Monomer-
based rates are important in this work due to the end goal of releasing pendant small molecules 
along the monomers of self-immolative systems.  
NMR studies were not beneficial for determining the ability to depolymerize the 
polyurethane portion of the copolymer due to overlapping chemical shifts.  To observe the 
necessary transitions of chemical bonds from polymer to monomer for successful 
depolymerization, we turned to ATR-IR spectroscopy (20 scans of pure polymer dissolved in 
THF).  This was used to detect the loss of bonds prevalent in the formation of polymer chains for 
each block in addition to the formation of key bonds found in the monomer (Fig. 3.5).    
 
 
 
 
Figure 3.5 ATR-IR spectra of 612k after being exposed to acidic conditions (red) and elevated temperature (green) and 
being compared to the control copolymer (blue). 
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Utilizing this, we could witness the loss of polymer and increase of monomer in the 
sample simultaneously.  Samples of 612k (5 mg in 1 mL THF) were left native, exposed to acidic 
conditions (addition of 0.5 mL of 20% HCl solution, and incubated for 3 hours), or elevated 
temperature (placed in a 65 °C water bath for 3 hours). For the heat-triggered depolymerization 
(highlighted in green in Fig. 3.5), there is a noticeable shift of stretch dominance in the 1680-
1720 cm-1 wavenumber region from the urethane-associated ester C=O stretch seen in 612k at 
1710 cm-1 (in blue) to the benzene-associated aldehyde C=O stretch observed at 1680 cm-1 for 
612k exposed to an elevated temperature (in green). This transition signifies the growth of 
aldehyde in the sample exposed to heat.   
The depolymerization event is further confirmed by the detected increase in the O-H 
stretch at 1360 cm-1. This increase is expected due to the reoccurrence of the initiating alcohol 
functionality of the polyurethane chain end group as PPA depolymerizes back to o-
phthalaldehyde.  The pH-triggered depolymerization (shown in red in Fig. 3.5) shows a stretch 
for O=C=O at 2345 cm-1, which signifies the expected release of carbon dioxide after the tert-
butyl carbamate is protonated and the tert-butyl carbocation is lost.  In addition, a growth in the 
C-O primary alcohol associated stretch at 1052 cm-1 is detected.  Because we do not see a shift 
toward a strong aldehyde peak as observed in the heat-triggered data, this growth of a primary 
alcohol tells us that we have an increased concentration of 4-amino benzyl alcohol, an expected 
product of the depolymerization of polymer 4.  
To further evaluate these results, we looked to confirm the substantial loss of molecular 
weight of 612k during the pH and temperature driven depolymerization events which should 
accompany the chemical bond shifts we observed with ATR-IR spectroscopy.  Taking the 
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samples of the same preparation previously described for ATR-IR, we filtered these samples 
with a 0.2 µm poly(tetrafluoroethylene) (PTFE) filter and analyzed them via GPC using THF as 
the mobile phase.  Five iterations of the samples were prepared and tested, showing no 
experimentally significant differentiation. The small molecules produced resolved in the void for 
this column system and was cut off to allow enhanced resolution of the higher molecular weight 
peaks. A characteristic spectrum for each sample is shown in Figure 3.6 along with their 
molecule weight and polydispersity information.     
 
Figure 3.6 GPC spectra and acquired GPC data for 612k after being exposed to an acidic 
environment and elevated temperature 
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612k+HCl 4300 5800 1.35
612k+65C 6200 10,000 1.61
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The initial spectrum compared to those of the depolymerized versions of 612k show a 
drastic change in molecular weight.  These results provide evidence that the data from NMR and 
ATR-IR spectroscopy validly show the occurrence of polymerization events which occur 
independently of the non-triggered portion of the copolymer.  The product of heat-induced 
depolymerization provided a GPC trace which was calculated to be 6200 g/mol with regard to 
the calibration curve produced from polystyrene standards.  This is quite close to the original 
polymer used as the macroinitiator (see dotted overlay of 47.5k in Figure 3.6).  The GPC trace for 
the pH-triggered depolymerization of 612k was calculated to be 4300 g/mol, which matches the 
projected molecular weight based on the molecular weight of the macroinitiator utilized.  
 To confirm that our results were indicative of a depolymerization and not a degradation, 
a study was conducted to ensure that our degradation products were monomers.  Both PPA and 
PBHMPC are insoluble in methanol, however the phthalaldehyde and BHMPC monomers are 
both soluble in this solvent.  To take advantage of this, the PPA-b- PBHMPC block copolymer 
was suspended in the deuterated solvent, methanol-d4, and exposed to conditions similar to those 
previously described for heat-induced and pH-induced depolymerization studies.  The analyzed 
samples were monitored via 1H NMR with the hypothesis that the experiments would solubilize 
portions of the polymer based on the stimulus administered.  The results indeed showed spectra 
identical to that of pure o-phthalaldehyde and the BHMPC monomer for heat-induced and pH-
induced studies respectively. 
3.4 Development of Multi-drug Releasing Polymersomes 
The success of selectively depolymerizing the two blocks of copolymer 6 led the pursuit 
of such results in biologically relevant polymeric systems.  To do this, we chose to form 
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polymersomes which could house two dyes to be released independently.  Polymersomes have 
displayed the ability to release drugs to specific regions of the body in a controllable manner and 
can house targeting moieties on their outer shell.30-32 We intend to use the hydrophobic dye Nile 
Red and the hydrophilic dye Blue Dextran to model the release of drugs from our polymersomes.  
The proposed method for synthesizing these vesicles is shown in Figure 3.7.   
 
 
Figure 3.7 Illustration of Polymersome formation using amphiphilic blocks for multi-drug 
encapsulation 
 
 The hydrophobic block of our diblock copolymer will be polymer 4, which allows us to 
maintain the previously described ability to depolymerize a portion of the polymersome in 
response to an acidic environment. It is expected that the controlled depolymerization will allow 
the controlled released of the Nile Red dye from the hydrophobic core.  The hydrophilic block 
will be poly[poly(ethylene glycol)methacrylate] (PPEGMA).  This polymer has been used to 
allow the release of drugs in micellar vesicles32-36 by manipulating its LCST, which varies based 
on the length of the PEG chain.37-39 Using temperature to control the release of Blue Dextran, 
without an evident release of Nile Red from the particles, and vice versa using changes in pH, 
	 	
	
	
	 89 
will constitute success in this system of a discriminate response to orthogonal stimuli and will be 
the first report of such a system. 
3.4.1 Synthesis of Amphiphilic Diblock Copolymer for Multi-drug Release from 
Polymerosomes 
 
3.4.1.a Synthesis of Hydrophilic block 10: 
 
 To create an amphiphilic copolymer for forming polymersomes, the copper catalyzed 
azide/alkyne cycloaddition (CuAAC) click reaction was chosen as a suitable method.  This will 
allow the step growth polymer and chain growth polymer to be covalently connected and act as a 
stable spacer between the two blocks during the depolymerization events. This reaction is outline 
in Scheme3.3. 
 
Scheme 3.3 Formation of amphiphilic polymer through Copper catalyzed azide/alkyne 
cycloaddition click reaction 
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 We first must synthesize an azide-bearing block and an alkyne-bearing block.  We chose 
to synthesize PPEGMA bearing an azide as our hydrophilic block due to the ability to place this 
moiety on a chain transfer agent (CTA).  Using this CTA for reversible addition-fragmentation 
chain-transfer (RAFT) polymerization will allow the growth of PPEGMA with an azide end cap 
on the chains on the polymer (polymer 10).  We were able to achieve this synthesis with a yield 
of 74% using the schematic portrayed in Scheme 3.4. 
 
Scheme 3.4 Synthetic route toward azide-bearing hydrophilic block 10 
 
3.4.1.b Synthesis of Hydrophobic Block 12: 
 As previously discussed, the Boc end capped polyurethane used in previous studies was 
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synthesizing a complement to the monomer to be utilized in the polymerization of the 
polyurethane as the initiator of polymer growth (Scheme 3.5).  Doing so allowed the synthesis of 
polymer 12. 
 
 
Scheme 3.5 Synthetic route toward alkyne-bearing hydrophobic block 12 
 
3.4.1.c Future Directions 
 Having successfully synthesized polymer 10 and polymer 12, the formation of an 
amphiphilic diblock copolymer can be obtained.  This polymer will be used in a water-in-oil 
suspension of Nile Red to create a vesicle with a Nile Red-filled hydrophobic core.  After 
allowing the solvent to evaporate, a subsequent suspension using an oil-in-water method with 
Blue Dextran will create an inner hydrophilic shell to encapsulate the dye with additional 
polymer.  The size and aggregation measurements will be determined from confocal microscopy.  
After determination of the LCST of the copolymer, the polymersomes will be exposed to 
different magnitudes of the two stimuli, heat and acid.  Using fluorescence microscopy, the 
release kinetics of these two dyes will be measured.  Once the ability to control the release of the 
dyes is observed, in vivo mice studies will be completed to investigate the biocompatibility and 
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toxicity of these polymersomes before and after depolymerization.  This novel work has 
importance in the field of biomaterials and will shape the future of cancer-battling drugs and 
functionality in polymeric scaffolds. 
3.5 Conclusions 
  The novel synthesis of a polyacetal-block-polyurethane copolymer was achieved which 
possesses the ability to depolymerize both selectively and in response to orthogonal stimuli.  It 
was also shown the depolymerization event could be accomplished without affecting the nature 
of the neighboring polymeric block.  The synthesis of low molecular weight 3 was completed via 
an anionic polymerization mechanism. It was also synthesized as a block in a diblock copolymer 
by utilizing polyurethanes as a macroinitiator.  The facile, thermally controlled depolymerization 
of 3 was observed by the growth of o-phthalaldehyde in 1H NMR spectra as a function of the 
time while exposed to elevated temperatures.  The average rate of depolymerization of the 
homopolymer at 55 °C was found to be roughly 2% weight loss/minute, and a tenth of this when 
it is appended to a thermally-stable polyurethane block.  This rate of depolymerization was 
shown to be sensitive to the exposure temperature. Polyurethanes possessing Boc end group 
functionality were synthesized and shown to readily depolymerize with kinetics proportional to 
the acidity of the environment.  Polymer 4 showed optimal use as an acid-degradable block, and 
was further studied as a block of the polyacetal-block-polyurethane copolymer.  The diblock 
copolymer 6 was analyzed for both its ability to depolymerize in response to heat (0.83 
monomeric units/min, 0.33 monomeric units/min, and 0.11 monomeric units/min for 100 °C, 80 
°C, and 55 °C respectively) and to acids by GPC, and ATR-IR. NMR studies were also 
completed to confirm the head-to-tail depolymerization occurring created monomers and no 
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other metabolites.  To our knowledge, this is the first report of a multi-responsive material 
capable of a discriminate, on-demand depolymerization. The synthesis of polymers 10 and 12 for 
use in a multi-drug releasing polymersome by the same mechanism as polymer 6 was 
accomplished.  A CuAAC click reaction of these polymers will allow the trial of a vesicle that 
will selectively release dyes on-demand and at a controllable rate. 
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CHAPTER 4: CHARACTERIZATION OF MUCINS TO AID THE DEVELOPMENT OF 
MUCOLYTIC AGENTS 
 
4.1 Introduction 
 Pulmonary diseases are of high concern to biochemists that are finding effective therapies 
for affected populations and to biophysicists searching for scientific understandings of the 
biological occurrences these diseases impose on the lungs and other portions of the respiratory 
tract.  Diseases studied heavily in this realm include asthma, chronic obstructive pulmonary 
disorder (COPD), and cystic fibrosis (CF).  A commonality of these is the hypersecretion of 
mucus.  The respiratory tract relies on mucociliary clearance (MCC) from the frequent beating of 
cilia on epithelial cells, and cough clearance as the two prominent methods for removing mucus 
from airways.1 Because one of the functions of pulmonary mucus is to trap viruses and bacteria 
before they can attack the lining of airways, the immune system relies on this clearance of mucus 
as a first line of defense.2-4  
 The hypersecretion of mucus that occurs in diseased individuals prevents proper 
clearance via MCC or coughing from occurring.5-7 The MUC genes which are relevant in the 
respiratory tract are MUC5B and MUC5AC.8 These two genes are very viscoelastic and can be 
quite dense, being molecular weights of up to 40 MDa.5 In patients with asthma, COPD, or CF, 
these large MUC genes are accompanied by sputum in the mucus gel network.  Sputum consists 
of DNA and other polypeptides and in conjunction with normal mucus, increases the viscosity 
and elasticity of the gel.7 This poses extreme issues for the diseased patients, causing wheezing, 
constant coughing, and difficulty breathing.9 
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 To ease this burden for patients, methods of breaking down mucin macromolecular 
networks are used.  This most common method is using a disulfide bond reducing agent as 
several disulfide bonds are along the polymeric backbone of mucins in their cysteine-rich 
regions.  N-acetylcysteine (NAC) is the most commonly used reducing agent for patients with 
pulmonary diseases around the world.10 However, many have found that it is not the most 
effective method for reducing mucins. In vitro, partially due to the high pKa (9.0) of the NAC 
thiol group, the monothiol nature of NAC produces a very slow reduction of disulfide bonds.11  
Also, it was observed in vivo that the small size of NAC makes it rapidly absorbed from the 
epithelial surface of airways, giving it a very short half-life.12  Even at high concentrations 
(1.2M), NAC could not provide experimentally significant reduction of mucins in clinical 
testing. 
 Scientists at Parion Sciences (with aid of UNC-Chapel Hill TPPG investigators under the 
NHLBI sponsored CADET program) synthesized a series of thiol based compounds to out-
perform the current mucolytic reducing agents on the market.  The latest candidate has shown 
efficacy in vitro in reducing the molecular weight of mucin genes MUC5AC and MUC5B and 
has features within its chemical structure that allow it to outperform NAC in areas of key 
concern.   
 Current molecular weight estimations have been performed using western blotting, which 
is the standard test method for characterizing the size of samples in biological sciences.13 Though 
quick and useful, western blot testing has its limitations.  It provides information as a molecular 
weight range and in relation to a marker, thus it cannot provide detailed quantitative information 
such as the number-average molecular weight of samples and their polydispersity.14, 15   
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 Gel Permeation Chromatography (GPC) is an indirect method for measuring molecular 
weight as well, but it has the ability to provide relative information on number-average and 
weight-average molecular weight, thus providing the polydispersity.  It also can separate 
different molecular weight populations under optimized testing parameters for the sample.  GPC 
has been used in characterizing mucin samples utilizing Sepharose CL2B gel as the stationary 
phase in columns.  Mucins do have the ability to travel through this gel due to its adequate pore 
size (70 kDa to 40 MDa for globular proteins), but separation of mucins through this gel would 
take columns of lengths that would produce reasonable data within a time scale of days.   
 It is hypothesized that using columns of smaller particle size than Sepharose CL2B (45 
µm), but similar pore sizes, we can quickly resolve mucin samples and fractionate a mucin 
distribution based on molecular weight.  We report the use of a Shodex OHpak SB-807 HQ 
column (particle size of 35 µm) and a series of Waters Ultrahydrogel 1000 columns (particles 
size of 12 µm) to accurately determine the molecular weight of mucins.  Such a quantitative tool 
will be highly useful for drug development in the realm of mucolytic agents and for scientists to 
gain an understanding of the dynamics of mucin biopolymers under various conditions. 
4.2 Experimental 
4.2.1 Materials 
 Water (HPLC Grade, Mobile phase for HPLC applications) was used as purchased from 
Fisher Scientific.  Phosphate buffered saline (powder, pH 7.4, for preparing 1 L solutions) was 
mixed with HPLC grade H2O and filtered through a 1µm membrane to use for GPC samples. 
Guanidine Hydrochloride (99.5%), was mixed with HPLC grade H2O at a concentration of 4M 
and used as mobile phase for GPC. 
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4.2.2 GPC 
4.2.2.a GPC of Salivary Mucins 
A Waters 2695 Separations Module with a Waters 2414 Refractive index detector was 
used. Three Ultrahydrogel 1000 columns were used in series with HPLC-grade H2O as the 
mobile phase with a flow rate of 0.80 mL/min. The instrument kept samples at room 
temperature. Average molar mass was derived from a calibration curve based on a series of 
poly(styrenesulfonate) (PSS) standards ranging from 20000 to 3,300,000 g mol−1. 
4.2.2.b GPC of High Molecular Weight Mucins 
An Agilient 1260 Infinity GPC System with a Wyatt Optilab Refractometer and a Wyatt 
DAWN HELEOS II Multi-Angle Light Scattering (MALS) detector was used.  A Shodex OHpak 
SB-807 HQ column was used with HPLC-grade H2O and Phosphate-buffered Saline as the two 
choices for the mobile phase.  The instrument kept samples at room temperature.  
4.2.3 Mucin Sample Preparation 
4.2.3.a Saliva samples 
 Saliva samples were collected by the following method: The mouth was rinsed out 
vigorously three times to ensure no contaminants remained.  A large piece of Parafilm (two 
inches) was then folded and chewed to increase saliva production.  Saliva was collected in a vial 
stored at 0 °C and allowed to sit for 1 hour to allow settling.  After one hour, the supernatant was 
collected via needle and syringe, stored in a separate vial at 0 °C, and because of the very dilute 
nature of collection, was considered ready for GPC analysis.  Typical collection size was 20 mL. 
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4.2.3.b Human Bronchial Epithelial (HBE) mucus samples  
 HBE cultures were prepared by a postdoctorate member of the Kesimer laboratory using 
a published method.16 MUC5B and MUC5AC mucins were grown from these cultures, and 
collected in the bronchial epithelial growth medium (BEGM).  Concentrations of mucins were 
determined via osmotic pressure calculations, and the samples were properly diluted to 1 mg/mL 
concentration for GPC measurements. 
4.3 Results and Discussion 
4.3.1 Characterization of Salivary Mucins 
4.3.1.a Optimized Spectrum of Salivary Mucins 
 After optimizing the flow rate, a telling distribution of salivary mucin populations were 
resolved using three Waters Ultrahydrogel 1000 columns.  The resulting chromatogram and 
molecular weight data is shown below in Figure 4.1 
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Figure 4.1 GPC chromatogram of salivary mucins in HPLC H2O and calculated molecular 
weights from calibration curve produced using PSS standards 
 
 The chromatogram shows the clear resolution of MUC5B and MUC7 in two separate 
molecular weight distributions, as opposed to previously reported data which show only one 
peak for all proteins present in the sample.  It should also be noted that the saliva sample was 
able to be resolved in under 30 minutes.  The molecular weights determined by integration of the 
resolved peaks closely resemble the molecular weight data reported in the literature for salivary 
mucins.17   
Though a distribution of the two relevant mucins was achieved, it was evident that the 
overall mucin concentration decreased after eluting through the column system.  We 
hypothesized that this was due to an interaction between the mucins and the stationary phase of 
the column system.  This was confirmed by running a guanidine mobile phase through the 
Mucin Mn Mw PDI
MUC5B 3.57 MDa 6.24 MDa 1.75
MUC7 162 KDa 302 KDa 1.87
1 6 11 16 21 26 31 36 41
Retention Time (min)
MUC5B
MUC7
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system.  Mucins bear many “sticky” domains, and guanidine is capable of reducing the adhesion 
of these domains to the stationary phase of the columns.  Rinses with guanidine were carried out 
between each mucin sample analysis in order to ensure only the native mucins were being 
observed.    
4.3.1.b Denaturation Study of Mucins 
 Because biological proteins denature over time at room temperature, and GPC analysis 
was unable to be conducted at temperatures lower than room temperature, a study was completed 
on saliva samples to understand the magnitude of denaturation which occurs after the time it 
takes a GPC sample to elute through the column system of our methodology (50 min).  The 
observed denaturation is shown in Figure 4.2. 
 
 
Figure 4.2 Mucin denaturation study using GPC in HPLC H2O 
 
8 13 18 23 28
Retention Time (min)
T=0	min
T=60	min
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 The chromatograms show that the MUC5B peak disappears after one hour of incubation 
at room temperature. The MUC7 concentration also decreases, in addition to the small proteins 
within the sample (shown after 28 mins).  This gain of information showed the importance of 
running samples immediately after preparation. 
4.3.2 Characterization of High Molecular Weight Mucins 
 The analysis of high molecular weight mucins is a lot less trivial than that of salivary 
mucins because most polymer chromatography methods are not meant for high molecular weight 
polypeptides.  The ability for these mucins to interact with most typical stationary phases is also 
problematic.  It was found that the Shodex OHpak SB-series columns were sufficient in 
resolving the high molecular weight mucins found in most pulmonary disease-inflicted patients.  
This data is shown Figure 4.3. 
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Figure 4.3 GPC spectra of HBE mucins in PBS compared to PSS standards 
 It was interesting that the two mucin types analyzed (MUC5B and MUC5AC) resolved at 
molecular weights less than that of the monodisperse 1 MDa PSS standard. Hypotheses for why 
this occurred include that the size of the PSS in the PBS mobile phase swells differently from 
that of the mucins, in which case a different polyelectrolyte will be needed to model the size of 
mucins and their elution in our column system. Another hypothesis is that the HBE mucus are 
not as mature in growth as anticipated when collected.   
Future work on this project will require a solvent study to determine the effects of PBS 
and H2O on the size of PSS and the mucins in question, alike.  In addition, pairing the GPC 
results with dynamic light scattering (DLS) information as well as rheology will help with 
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identifying the cause of variation seen in experimental GPC data from what is theoretically 
expected. 
4.4 Conclusions 
 We report the first GPC resolved distribution of mucin populations in saliva.  We also 
report the resolution of high molecular weight mucins via a GPC system.  The next steps of this 
work require solvent studies for the optimization of GPC methods and the determination of ideal 
polyelectrolytes for modeling the dynamics and size of mucin polypeptides.  These findings will 
assist the drug development efforts of scientist in creating effective mucolytic agents for the 
treatment of pulmonary diseases that cause hypersecretion of mucus. 
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APPENDIX A: SUPPLEMENTARY INFORMATION FOR CHAPTER 2 
EPR SPIN PROBE INVESTIGATION OF THE SAG SURFACE DEFECT IN ACRYLIC 
COATINGS DURING COALESCENCE 
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Figure A1 EPR spectrum of TEMPO-doped coating at t=0 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A2 EPR spectrum of TEMPO-doped coating at t=5 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A3 EPR spectrum of TEMPO-doped coating at t=10 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A4 EPR spectrum of TEMPO-doped coating at t=15 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A5 EPR spectrum of TEMPO-doped coating at t=20 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A6 EPR spectrum of TEMPO-doped coating at t=25 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
 
  
300 400 500 600 700
-200
0
200
Field (mT)
	 	
	
	
	 116 
 
Figure A7 EPR spectrum of TEMPO-doped coating at t=30 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A8 EPR spectrum of TEMPO-doped coating at t=35 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A9 EPR spectrum of TEMPO-doped coating at t=40 minutes (center field of 336.38 mT, 
sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A10 EPR spectrum of TEMPO-doped coating at t=50 minutes (center field of 336.38 
mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A11 EPR integrated spectrum of TEMPO-doped coating at t=5 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A12 EPR integrated spectrum of TEMPO-doped coating at t=10 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A13 EPR integrated spectrum of TEMPO-doped coating at t=15 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A14 EPR integrated spectrum of TEMPO-doped coating at t=20 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A15 EPR integrated spectrum of TEMPO-doped coating at t=25 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
 
 
  
	 	
	
	
	 125 
 
Figure A16 EPR integrated spectrum of TEMPO-doped coating at t=30 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A17 EPR integrated spectrum of TEMPO-doped coating at t=35 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A18 EPR integrated spectrum of TEMPO-doped coating at t=40 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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Figure A19 EPR integrated spectrum of TEMPO-doped coating at t=50 minutes (center field of 
336.38 mT, sweep width of 5 mT, modulation width of 1 Gauss) 
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APPENDIX B: SUPPLEMENTARY INFORMATION FOR CHAPTER 3 
TRIGGERED DEPOLYMERIZATION OF POLYURETHANE-BASED MATERIALS IN 
RESPONSE TO ORTHOGONAL STIMULI 
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Scheme B1 Synthetic procedure for PMDIBD A-A + B-B –type control polyurethane polymer 
 
 
 
 
 
1H NMR Spectra of Synthesized and Depolymerized Compounds: 
 
 
 
Figure B1: 1H NMR of Monomer 1 
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Figure B2: 1H NMR of Monomer 2 
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Figure B3: 1H NMR of Polymer 3 
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Figure B4: 1H NMR of Polymer 4 
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Figure B5: 1H NMR of Polymer 6 
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Figure B6: 1H NMR of Polymer 6 after 20 min of heating @ 80 °C 
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Figure B7: 1H NMR of Polymer 6 after 40 min of  heating @ 80 °C 
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Figure B8: 1H NMR of Polymer 6 after 60 min of heating @ 80 °C 
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Figure B9: 1H NMR of Molecule 7  
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Figure B10: 1H NMR of Molecule 8  
  
	 	
	
	
	 140 
 
Figure B11: 1H NMR of Molecule 9  
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Figure B12: 1H NMR of Polymer 10 
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Figure B13: 1H NMR of Molecule 11 
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Figure B14: 1H NMR of Polymer 12 
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1H NMR Data Obtained for Kinetics: 
 
Temp 0 min 10 min 20 min 30 min 40 min 50 min 60 min 
25 °C 0 0 0.4 0.8 1.8 2.4 4.4 
45 °C 0 0.4 1.4 3.2 5.8 9.2 14.1 
55 °C 0 1.3 5.5 12.4 17.1 19.5 29.3 
65 °C 0 4.1 7.7 16.9 27.4 34.3 52.9 
75 °C 0 10.4 22.3 31.1 40.4 53.2 68.1 
 
Table B1: Depolymerization percentages based on integration of aldehyde peak after 
depolymerization of Polymer 3 at described temperatures and durations 
 
 
 
Time (min) % 
Depolymerization 
0 0 
15 5.75 
75 8.5 
90 16.2 
150 18.9 
165 29 
225 32.1 
240 45.3 
Table B2: Depolymerization percentages based on integration of aldehyde peak after 
depolymerization of Polymer 3 and temperature fluctuations to control the rate as described in 
Fig. 3.4C 
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ATR FT-IR Spectra: 
 
 
 
Figure B15: ATR-IR Spectrum of Polymer 6 
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Figure B16: ATR-IR Spectrum of Polymer 6 after 3 hours of exposure to 65 °C environment 
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Figure B17: ATR-IR Spectrum of Polymer 6 after 3 hours of exposure to acidic environment 
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GPC Data: 
 
 
Figure B18: GPC Data of Polymer 413k after exposure to different magnitudes of Trifluoroacetic 
acid to observe PDI transition 
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Figure B19: GPC chromatogram of Polymer 613k 
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Figure B20: GPC chromatogram of Polymer 613k after exposed to acidic conditions 
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Figure B21: GPC chromatogram of Polymer 613k after exposed to elevated temperature (65°C) 
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GPC Data of Control Polymers: 
 
 
Sample <Mn> 
(g/mol) 
<Mw> 
(g/mol) 
PDI 
1 2200 3100 1.4 
2 3100 4600 1.5 
3 4300 5600 1.3 
Table B3: GPC Data of Polymer 3 
 
 
 
 
 
 
Sample <Mn> 
(g/mol) 
<Mw> 
(g/mol) 
PDI 
1 4300 4800 1.1 
2 9700 13000 1.3 
3 14000 19000 1.5 
Table B4: GPC Data of Polymer 5 
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Sample <Mn> 
(g/mol) 
<Mw> 
(g/mol) 
PDI  
1 4261 6439 1.5 
2 13186 18739 1.42 
Table B5: GPC Data of PMDIBD 
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APPENDIX C: SUPPLEMENTARY INFORMATION FOR CHAPTER 4 
 
CHARACTERIZATION OF MUCINS TO AID THE DEVELOPMENT OF 
MUCOLYTIC AGENTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
	 	
	
	
	 155 
 
 
Figure C1 GPC chromatogram of 75 kDa PSS using CL2B column system in HPLC H2O 
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Figure C2 GPC chromatogram of 152 kDa PSS using CL2B column system in HPLC H2O 
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Figure C3 GPC chromatogram of 470 kDa PSS using CL2B column system in HPLC H2O 
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Figure C4 GPC chromatogram of 3.3 MDa PSS using CL2B column system in HPLC H2O 
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Figure C5 GPC chromatogram of unfiltered saliva using CL2B column system in HPLC H2O 
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Figure C6 GPC chromatogram of 680 kDa PSS using Shodex OHpak column system in PBS 
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Figure C7 GPC chromatogram of 1 MDa PSS using Shodex OHpak column system in PBS 
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Figure C8 GPC chromatogram of 2 MDa PSS using Shodex OHpak column system in PBS 
 
 
 
  
	 	
	
	
	 163 
 
 
Figure C9 GPC chromatogram of HBE produced MUC5B mucus using Shodex OHpak column 
system in PBS 
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Figure C10 GPC chromatogram of HBE produced MUC5AC mucus using Shodex OHpak 
column system in PBS 
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Figure C11 GPC chromatogram of unfiltered salivary mucus using Ultrahydrogel column 
system in HPLC H2O 
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Figure C12 GPC chromatogram of unfiltered salivary mucus exposed to 1 mM of Parion 
mucolytic using Ultrahydrogel column system in HPLC H2O 
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Figure C13 GPC chromatogram of unfiltered salivary mucus exposed to 5 mM of Parion 
mucolytic using Ultrahydrogel column system in HPLC H2O 
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Figure C14 GPC chromatogram of unfiltered salivary mucus exposed to 10 mM of Parion 
mucolytic using Ultrahydrogel column system in HPLC H2O 
 
 
 
